AMG 423,0.23809523809523808,0.0,0.0,P17302,Heart disease
GRNCM-1,0.23809523809523808,0.0,0.0,P17302,Heart disease
EVP-1001-1,0.23809523809523808,0.0,0.0,P17302,Heart disease
APL-180,0.23809523809523808,0.0,0.0,P17302,Heart disease
MX-6120,0.23809523809523808,0.0,0.0,P17302,Heart disease
ATPase,0.23809523809523808,0.0,0.0,P17302,Heart disease
Beperminogene perplasmid,0.23809523809523808,0.0,0.0,P17302,Heart disease
Perflubutane lipid microsphere-encapsulated,0.23809523809523808,0.0,0.0,P17302,Heart disease
Stem cell therapy; heart disease,0.23809523809523808,0.0,0.0,P17302,Heart disease
StromaCel,0.23809523809523808,0.0,0.0,P17302,Heart disease
CGS-26393,0.23809523809523808,0.0,0.0,P17302,Heart disease
Alferminogene tadenovec,0.23809523809523808,0.0,0.0,P17302,Heart disease
N-3601,0.23809523809523808,0.0,0.0,P17302,Heart disease
Tin-117m-labeled annexin,0.23809523809523808,0.0,0.0,P17302,Heart disease
B-type natriuretic peptide,0.23809523809523808,0.0,0.0,P17302,Heart disease
Octafluoropropane perflutren lipid microsphere,0.23809523809523808,0.0,0.0,P17302,Heart disease
ARC1779,0.23809523809523808,0.0,0.0,P17302,Heart disease
Inamrinone,0.23809523809523808,0.0,0.0,P17302,Heart disease
Idraparinux,0.23809523809523808,0.0,0.0,P17302,Heart disease
Human chorionic gonadotropin,0.23809523809523808,0.0,0.0,P17302,Heart disease
Cenderitide,0.23809523809523808,0.0,0.0,P17302,Heart disease
FT-101,0.23809523809523808,0.0,0.0,P17302,Heart disease
NP-02,0.23809523809523808,0.0,0.0,P17302,Heart disease
Epothilone D,0.0,0.0,0.0,Q9UBC3,Breast cancer
ARN-810,0.0,0.0,0.0,Q9UBC3,Breast cancer
Anti-CD3 and anti-Her2/neu bispecific antibody-armed activated T cells,0.0,0.0,0.0,Q9UBC3,Breast cancer
AntiHer2-XTEN-Docetaxel,0.0,0.0,0.0,Q9UBC3,Breast cancer
Nomegestrol acetate,0.0,0.0,0.0,Q9UBC3,Breast cancer
COUMATE,0.0,0.0,0.0,Q9UBC3,Breast cancer
NeuVax,0.0,0.0,0.0,Q9UBC3,Breast cancer
Lobaplatin,0.0,0.0,0.0,Q9UBC3,Breast cancer
Herzyme,0.0,0.0,0.0,Q9UBC3,Breast cancer
ITL-1636,0.0,0.0,0.0,Q9UBC3,Breast cancer
MX-781,0.0,0.0,0.0,Q9UBC3,Breast cancer
IMT-1012,0.0,0.0,0.0,Q9UBC3,Breast cancer
MB-300,0.0,0.0,0.0,Q9UBC3,Breast cancer
Danazol,0.0,0.0,0.0,Q9UBC3,Breast cancer
RAD-1901,0.0,0.0,0.0,Q9UBC3,Breast cancer
Maraciclatide,0.0,0.0,0.0,Q9UBC3,Breast cancer
KH064,0.0,0.0,0.0,Q9UBC3,Breast cancer
LOSOXANTRONE,0.0,0.0,0.0,Q9UBC3,Breast cancer
Efungumab,0.0,0.0,0.0,Q9UBC3,Breast cancer
LY2784544,0.0,0.0,0.0,Q9UBC3,Breast cancer
HM-2002,0.0,0.0,0.0,Q9UBC3,Breast cancer
RG7321,0.0,0.0,0.0,Q9UBC3,Breast cancer
Labeled LH superagonist,0.0,0.0,0.0,Q9UBC3,Breast cancer
Droloxifene,0.0,0.0,0.0,Q9UBC3,Breast cancer
Photodynamic immunotherapy,0.0,0.0,0.0,Q9UBC3,Breast cancer
KW-2581,0.0,0.0,0.0,Q9UBC3,Breast cancer
Pertuzumab companion diagnostic,0.0,0.0,0.0,Q9UBC3,Breast cancer
LJM716,0.0,0.0,0.0,Q9UBC3,Breast cancer
SMART ABL-364,0.0,0.0,0.0,Q9UBC3,Breast cancer
99mTc-tetrofosmin,0.0,0.0,0.0,Q9UBC3,Breast cancer
Estradiol,0.0,0.0,0.0,Q9UBC3,Breast cancer
Cabazitaxel,0.0,0.0,0.0,Q9UBC3,Breast cancer
SR-13654,0.0,0.0,0.0,Q9UBC3,Breast cancer
PF-05280014,0.0,0.0,0.0,Q9UBC3,Breast cancer
AA-102,0.0,0.0,0.0,Q9UBC3,Breast cancer
CMB-401,0.0,0.0,0.0,Q9UBC3,Breast cancer
EDD7H9,0.0,0.0,0.0,Q9UBC3,Breast cancer
SiRNA therapy; breast cancer,0.0,0.0,0.0,Q9UBC3,Breast cancer
MX-6162,0.0,0.0,0.0,Q9UBC3,Breast cancer
KW-2450,0.0,0.0,0.0,Q9UBC3,Breast cancer
Anastrozole,0.0,0.0,0.0,Q9UBC3,Breast cancer
Beta 1-6 glucan-conjugated trastuzumab,0.0,0.0,0.0,Q9UBC3,Breast cancer
GPI-0100,0.0,0.0,0.0,Q9UBC3,Breast cancer
Tamoxifen,0.0,0.0,0.0,Q9UBC3,Breast cancer
Tesetaxel,0.0,0.0,0.0,Q9UBC3,Breast cancer
OSE2101,0.0,0.0,0.0,Q9UBC3,Breast cancer
17beta-HSD1 inhibitor,0.0,0.0,0.0,Q9UBC3,Breast cancer
AZD-4992,0.0,0.0,0.0,Q9UBC3,Breast cancer
Levormeloxifene non-steroidal,0.0,0.0,0.0,Q9UBC3,Breast cancer
OPT-822,0.0,0.0,0.0,Q9UBC3,Breast cancer
RG7422,0.0,0.0,0.0,Q9UBC3,Breast cancer
GW-974,0.0,0.0,0.0,Q9UBC3,Breast cancer
MM-302,0.047619047619047616,0.0,0.0,Q9UBC3,Breast cancer
Encapsulated cells,0.0,0.0,0.0,Q9UBC3,Breast cancer
Trastuzumab-DM1,0.0,0.0,0.0,Q9UBC3,Breast cancer
AS-1402,0.0,0.0,0.0,Q9UBC3,Breast cancer
AS-1403,0.0,0.0,0.0,Q9UBC3,Breast cancer
Taxol/Paraplatin/Herceptin,0.0,0.0,0.0,Q9UBC3,Breast cancer
17AAG,0.0,0.0,0.0,Q9UBC3,Breast cancer
HER-2VAX,0.0,0.0,0.0,Q9UBC3,Breast cancer
Alovudine,0.0,0.0,0.0,Q9UBC3,Breast cancer
TPIV100,0.0,0.0,0.0,Q9UBC3,Breast cancer
VER 50589,0.0,0.0,0.0,Q9UBC3,Breast cancer
Demobesin,0.0,0.0,0.0,Q9UBC3,Breast cancer
Eribulin,0.0,0.0,0.0,Q9UBC3,Breast cancer
Rucaparib,0.0,0.0,0.0,Q9UBC3,Breast cancer
GBP-1a,0.0,0.0,0.0,Q9UBC3,Breast cancer
BreMel/TNF alpha,0.0,0.0,0.0,Q9UBC3,Breast cancer
BZL-101,0.0,0.0,0.0,Q9UBC3,Breast cancer
OBP-301,0.0,0.0,0.0,Q9UBC3,Breast cancer
RO-4929097,0.0,0.0,0.0,Q9UBC3,Breast cancer
Tigatuzumab,0.0,0.0,0.0,Q9UBC3,Breast cancer
Idoxifene,0.0,0.0,0.0,Q9UBC3,Breast cancer
XL-765,0.0,0.0,0.0,Q9UBC3,Breast cancer
MabionHER2,0.0,0.0,0.0,Q9UBC3,Breast cancer
BreMel/rGel,0.0,0.0,0.0,Q9UBC3,Breast cancer
HER-2/neu-based modified vaccinia ankara vaccine,0.0,0.0,0.0,Q9UBC3,Breast cancer
Liposome encapsulated paclitaxel,0.0,0.0,0.0,Q9UBC3,Breast cancer
HER-2 Protein AutoVac,0.0,0.0,0.0,Q9UBC3,Breast cancer
YN-968D1,0.0,0.0,0.0,Q9UBC3,Breast cancer
Sch-58500,0.0,0.0,0.0,Q9UBC3,Breast cancer
VT-1,0.0,0.0,0.0,Q9UBC3,Breast cancer
Breast cancer vaccine,0.0,0.0,0.0,Q9UBC3,Breast cancer
Satumomab Pendetide,0.034013605442176874,0.0,0.0,Q9UBC3,Breast cancer
ON-04,0.0,0.0,0.0,Q9UBC3,Breast cancer
Fsn-1006,0.0,0.0,0.0,Q9UBC3,Breast cancer
Gestrinone,0.0,0.0,0.0,Q9UBC3,Breast cancer
TgDCC-E1A,0.0,0.0,0.0,Q9UBC3,Breast cancer
Dendritic cell therapy,0.0,0.0,0.0,Q9UBC3,Breast cancer
LADIRUBICIN,0.0,0.0,0.0,Q9UBC3,Breast cancer
ARZOXIFENE,0.0,0.0,0.0,Q9UBC3,Breast cancer
Afimoxifene,0.0,0.0,0.0,Q9UBC3,Breast cancer
Esterified estrogens,0.0,0.0,0.0,Q9UBC3,Breast cancer
P10s-Padre/Montanide ISA 51 vaccine,0.0,0.0,0.0,Q9UBC3,Breast cancer
Onartuzumab,0.0,0.0,0.0,Q9UBC3,Breast cancer
NB1011,0.0,0.0,0.0,Q9UBC3,Breast cancer
Nomifensine,0.0,0.0,0.0,Q9UBC3,Breast cancer
Polyamine,0.0,0.0,0.0,Q9UBC3,Breast cancer
MEDI-561,0.0,0.0,0.0,Q9UBC3,Breast cancer
Afeletecan,0.0,0.0,0.0,Q9UBC3,Breast cancer
YM-511,0.0,0.0,0.0,Q9UBC3,Breast cancer
Varlitinib,0.0,0.0,0.0,Q9UBC3,Breast cancer
Arcitumomab,0.047619047619047616,0.0,0.0,Q9UBC3,Breast cancer
Doxorubicin-CEA conjugate,0.0,0.0,0.0,Q9UBC3,Breast cancer
SNG-8023,0.0,0.0,0.0,Q9UBC3,Breast cancer
Steroid mimics,0.0,0.0,0.0,Q9UBC3,Breast cancer
OPT-822/OPT-821,0.0,0.0,0.0,Q9UBC3,Breast cancer
ScFv23/rGel,0.0,0.0,0.0,Q9UBC3,Breast cancer
ICO-25,0.0,0.0,0.0,Q9UBC3,Breast cancer
Buparlisib,0.0,0.0,0.0,Q9UBC3,Breast cancer
AFPep,0.0,0.0,0.0,Q9UBC3,Breast cancer
Zindoxifene,0.0,0.0,0.0,Q9UBC3,Breast cancer
Sagopilone,0.0,0.0,0.0,Q9UBC3,Breast cancer
IVVS-1001,0.0,0.0,0.0,Q9UBC3,Breast cancer
SF-1,0.0,0.0,0.0,Q9UBC3,Breast cancer
Foxy-5,0.0,0.0,0.0,Q9UBC3,Breast cancer
SAR256212,0.0,0.0,0.0,Q9UBC3,Breast cancer
Tc99-labeled 14F7 humanized mAb,0.0,0.0,0.0,Q9UBC3,Breast cancer
Rogletimide,0.0,0.0,0.0,Q9UBC3,Breast cancer
AE-37,0.0,0.0,0.0,Q9UBC3,Breast cancer
Gimatecan,0.0,0.0,0.0,Q9UBC3,Breast cancer
HTERT-VISA-BikDD nanoparticles,0.0,0.0,0.0,Q9UBC3,Breast cancer
SFV IL-12 gene therapy,0.0,0.0,0.0,Q9UBC3,Breast cancer
HER2/neu peptide vaccine,0.0,0.0,0.0,Q9UBC3,Breast cancer
Personalized cancer vaccine,0.0,0.0,0.0,Q9UBC3,Breast cancer
HER2 antigen-specific cancer immunotherapeutic,0.0,0.0,0.0,Q9UBC3,Breast cancer
Dexrazoxane,0.0,0.0,0.0,Q9UBC3,Breast cancer
HMAG-1 targeting GRSA,0.0,0.0,0.0,Q9UBC3,Breast cancer
NSC-645809,0.0,0.0,0.0,Q9UBC3,Breast cancer
AZD8931,0.0,0.0,0.0,Q9UBC3,Breast cancer
MAGE-101,0.0,0.0,0.0,Q9UBC3,Breast cancer
HKI-272,0.0,0.0,0.0,Q9UBC3,Breast cancer
Tetanolic acid,0.0,0.0,0.0,Q9UBC3,Breast cancer
Endoxifen,0.0,0.0,0.0,Q9UBC3,Breast cancer
MM-121,0.0,0.0,0.0,Q9UBC3,Breast cancer
EGF-SLiP fusion protein,0.0,0.0,0.0,Q9UBC3,Breast cancer
Zn-DPA-B,0.0,0.0,0.0,Q9UBC3,Breast cancer
Thiotepa,0.0,0.0,0.0,Q9UBC3,Breast cancer
Toremifene,0.0,0.0,0.0,Q9UBC3,Breast cancer
ARX-AHD,0.0,0.0,0.0,Q9UBC3,Breast cancer
MVA HER-2 AutoVac,0.0,0.0,0.0,Q9UBC3,Breast cancer
Mirostipen,0.0,0.0,0.0,Q9UBC3,Breast cancer
Recombinant pox virus vaccine,0.0,0.0,0.0,Q9UBC3,Breast cancer
BW-42,0.0,0.0,0.0,Q9UBC3,Breast cancer
Prosorba,0.0,0.0,0.0,Q9UBC3,Breast cancer
BIIB-021,0.0,0.0,0.0,Q9UBC3,Breast cancer
Crodox,0.0,0.0,0.0,Q9UBC3,Breast cancer
Capecitabine,0.0,0.0,0.0,Q9UBC3,Breast cancer
Virulizin,0.0,0.0,0.0,Q9UBC3,Breast cancer
Pbi-shSTMN1 LP,0.0,0.0,0.0,Q9UBC3,Breast cancer
AE37 peptide vaccine,0.0,0.0,0.0,Q9UBC3,Breast cancer
GM3 ganglioside vaccine,0.0,0.0,0.0,Q9UBC3,Breast cancer
ICI-164384,0.0,0.0,0.0,Q9UBC3,Breast cancer
BAM-002,0.0,0.0,0.0,Q9UBC3,Breast cancer
GSK-2302024A,0.0,0.0,0.0,Q9UBC3,Breast cancer
Brivanib,0.0,0.0,0.0,Q9UBC3,Breast cancer
17-Dmag,0.0,0.0,0.0,Q9UBC3,Breast cancer
99mTc-RP-527,0.0,0.0,0.0,Q9UBC3,Breast cancer
Amonafide,0.0,0.0,0.0,Q9UBC3,Breast cancer
Ixabepilone,0.0,0.0,0.0,Q9UBC3,Breast cancer
PINS,0.0,0.0,0.0,Q9UBC3,Breast cancer
PEV-6A,0.0,0.0,0.0,Q9UBC3,Breast cancer
KW-2170,0.0,0.0,0.0,Q9UBC3,Breast cancer
SLX-1016,0.0,0.0,0.0,Q9UBC3,Breast cancer
76Br-16alpha;17alpha-dioxolane progestin,0.0,0.0,0.0,Q9UBC3,Breast cancer
18F-fluorothymidine,0.0,0.0,0.0,Q9UBC3,Breast cancer
Cu64-CNND1-B,0.0,0.0,0.0,Q9UBC3,Breast cancer
Racotumomab,0.0,0.0,0.0,Q9UBC3,Breast cancer
Sialyl Lea-KLH conjugate vaccine,0.0,0.0,0.0,Q9UBC3,Breast cancer
Selective estrogen receptor degraders,0.0,0.0,0.0,Q9UBC3,Breast cancer
ABT-888,0.0,0.0,0.0,Q9UBC3,Breast cancer
AC480,0.0,0.0,0.0,Q9UBC3,Breast cancer
BIIB 2024,0.0,0.0,0.0,Q9UBC3,Breast cancer
ADXS-HER2,0.0,0.0,0.0,Q9UBC3,Breast cancer
TB-010,0.0,0.0,0.0,Q9UBC3,Breast cancer
Datelliptium chloride,0.0,0.0,0.0,Q9UBC3,Breast cancer
ERA-923,0.0,0.0,0.0,Q9UBC3,Breast cancer
Dalotuzumab,0.0,0.0,0.0,Q9UBC3,Breast cancer
Fulvestrant,0.0,0.0,0.0,Q9UBC3,Breast cancer
Pralatrexate,0.0,0.0,0.0,Q9UBC3,Breast cancer
Probodies,0.0,0.0,0.0,Q9UBC3,Breast cancer
Pirarubicin,0.0,0.0,0.0,Q9UBC3,Breast cancer
Pertuzumab,0.0,0.0,0.0,Q9UBC3,Breast cancer
111In-hEGF,0.0,0.0,0.0,Q9UBC3,Breast cancer
GPX-150D,0.0,0.0,0.0,Q9UBC3,Breast cancer
PD-0332991,0.0,0.0,0.0,Q9UBC3,Breast cancer
AVX901,0.0,0.0,0.0,Q9UBC3,Breast cancer
RL-6A,0.0,0.0,0.0,Q9UBC3,Breast cancer
Lapatinib,0.0,0.0,0.0,Q9UBC3,Breast cancer
Hedgehog labelled stem cells,0.0,0.0,0.0,Q9UBC3,Breast cancer
RG6046,0.0,0.0,0.0,Q9UBC3,Breast cancer
Surrobodies,0.0,0.0,0.0,Q9UBC3,Breast cancer
177Lu-AMBA,0.0,0.0,0.0,Q9UBC3,Breast cancer
Peplomycin,0.0,0.0,0.0,Q9UBC3,Breast cancer
Atamestane-plus- Toremifene,0.0,0.0,0.0,Q9UBC3,Breast cancer
Anatumomab mafenatox,0.0,0.0,0.0,Q9UBC3,Breast cancer
99mTc-sestamibi,0.0,0.0,0.0,Q9UBC3,Breast cancer
Talaporfin,0.0,0.0,0.0,Q9UBC3,Breast cancer
Brostallicin,0.0,0.0,0.0,Q9UBC3,Breast cancer
AFP464,0.0,0.0,0.0,Q9UBC3,Breast cancer
AVE-1642,0.0,0.0,0.0,Q9UBC3,Breast cancer
Ertumaxomab,0.0,0.0,0.0,Q9UBC3,Breast cancer
Vx-001,0.0,0.0,0.0,Q9UBC3,Breast cancer
Upamostat,0.0,0.0,0.0,Q9UBC3,Breast cancer
RHIZOXIN,0.0,0.0,0.0,Q9UBC3,Breast cancer
Aderbasib,0.0,0.0,0.0,Q9UBC3,Breast cancer
Trastuzumab,0.0,0.0,0.0,Q9UBC3,Breast cancer
AMG 386,0.0,0.0,0.0,Q9UBC3,Breast cancer
HE3235,0.0,0.0,0.0,Q9UBC3,Breast cancer
AMG 479,0.0,0.0,0.0,Q9UBC3,Breast cancer
Plant-based oncology candidate,0.0,0.0,0.0,Q9UBC3,Breast cancer
ANAVEX 2-73,0.0,0.0,0.0,Q9UBC3,Breast cancer
DPX-0907,0.0,0.0,0.0,Q9UBC3,Breast cancer
Acolbifene,0.0,0.0,0.0,Q9UBC3,Breast cancer
MM-111,0.0,0.0,0.0,Q9UBC3,Breast cancer
ICARITIN,0.0,0.0,0.0,Q9UBC3,Breast cancer
TriAb,0.0,0.0,0.0,Q9UBC3,Breast cancer
SBG,0.0,0.0,0.0,Q9UBC3,Breast cancer
Fluoxymesterone,0.0,0.0,0.0,Q9UBC3,Breast cancer
HeR2,0.0,0.0,0.0,Q9UBC3,Breast cancer
CT84.66,0.0,0.0,0.0,Q9UBC3,Breast cancer
P-276,0.0,0.0,0.0,Q9UBC3,Breast cancer
BP-C1,0.0,0.0,0.0,Q9UBC3,Breast cancer
SR 16234,0.0,0.0,0.0,Q9UBC3,Breast cancer
SP-MET-1,0.0,0.0,0.0,Q9UBC3,Breast cancer
Her-2-Bi-armed ATC,0.0,0.0,0.0,Q9UBC3,Breast cancer
ARC-100,0.0,0.0,0.0,Q9UBC3,Breast cancer
YM155,0.0,0.0,0.0,Q9UBC3,Breast cancer
SGN LIV1A,0.0,0.0,0.0,Q9UBC3,Breast cancer
NRLU-10,0.0,0.0,0.0,Q9UBC3,Breast cancer
VM-505,0.0,0.0,0.0,Q9UBC3,Breast cancer
Ad.hIL-12,0.0,0.0,0.0,Q9UBC3,Breast cancer
Rubratin,0.047619047619047616,0.0,0.0,P51654,Cancer
BYL719,0.047619047619047616,0.0,0.0,P51654,Cancer
TGF-beta receptor 1 kinase inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
TGF-beta receptor 1 kinase inhibitor,0.047619047619047616,0.0,0.0,P51654,Cancer
DMB mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
Refametinib,0.047619047619047616,0.0,0.0,P51654,Cancer
Isoquinoline alkaloids,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-05082566,0.047619047619047616,0.0,0.0,P51654,Cancer
Diethylnorspermine,0.047619047619047616,0.0,0.0,P51654,Cancer
ERIC-1,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-275183,0.047619047619047616,0.0,0.0,P51654,Cancer
Urelumab,0.047619047619047616,0.0,0.0,P51654,Cancer
CPD-VO,0.047619047619047616,0.0,0.0,P51654,Cancer
NPB-2,0.047619047619047616,0.0,0.0,P51654,Cancer
ARANOSE,0.047619047619047616,0.0,0.0,P51654,Cancer
NMK-36,0.047619047619047616,0.0,0.0,P51654,Cancer
RNA synthesis inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
Hsp 90 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
A-620223,0.047619047619047616,0.0,0.0,P51654,Cancer
PM-72G,0.047619047619047616,0.0,0.0,P51654,Cancer
BmAb-200,0.047619047619047616,0.0,0.0,P51654,Cancer
21-AMINOEPOTHILONE B,0.047619047619047616,0.0,0.0,P51654,Cancer
MDX-1459,0.047619047619047616,0.0,0.0,P51654,Cancer
Ortataxel,0.047619047619047616,0.0,0.0,P51654,Cancer
WBZ-7,0.047619047619047616,0.0,0.0,P51654,Cancer
CIGB-370,0.047619047619047616,0.0,0.0,P51654,Cancer
IGF-drug conjugates,0.047619047619047616,0.0,0.0,P51654,Cancer
NSC-364432,0.047619047619047616,0.0,0.0,P51654,Cancer
MN-201,0.047619047619047616,0.0,0.0,P51654,Cancer
Alpha amino acids,0.047619047619047616,0.0,0.0,P51654,Cancer
Dual PI3K-alpha/mTOR inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
NPS-1,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY 94-9343,0.047619047619047616,0.0,0.0,P51654,Cancer
NPS-2,0.047619047619047616,0.0,0.0,P51654,Cancer
Simotinib,0.047619047619047616,0.0,0.0,P51654,Cancer
RepliVec,0.047619047619047616,0.0,0.0,P51654,Cancer
SRI-21009,0.047619047619047616,0.0,0.0,P51654,Cancer
GS-156 mAb,0.047619047619047616,0.0,0.0,P51654,Cancer
CC-401,0.047619047619047616,0.0,0.0,P51654,Cancer
PRS-110,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1343,0.047619047619047616,0.0,0.0,P51654,Cancer
PNT-2258,0.047619047619047616,0.0,0.0,P51654,Cancer
BIM-46187,0.047619047619047616,0.0,0.0,P51654,Cancer
IGF-methotrexate conjugate,0.047619047619047616,0.0,0.0,P51654,Cancer
VAL-201,0.047619047619047616,0.0,0.0,P51654,Cancer
Ruthenium-based complexes,0.047619047619047616,0.0,0.0,P51654,Cancer
NV-196,0.047619047619047616,0.0,0.0,P51654,Cancer
CGP-55847,0.047619047619047616,0.0,0.0,P51654,Cancer
AMG 208,0.047619047619047616,0.0,0.0,P51654,Cancer
SPVF-2801-30,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1338,0.047619047619047616,0.0,0.0,P51654,Cancer
OBP-401,0.047619047619047616,0.0,0.0,P51654,Cancer
ICT-037,0.047619047619047616,0.0,0.0,P51654,Cancer
Vivia-577,0.047619047619047616,0.0,0.0,P51654,Cancer
Perillyl alcohol,0.047619047619047616,0.0,0.0,P51654,Cancer
CB-30865,0.047619047619047616,0.0,0.0,P51654,Cancer
RIG-I adjuvant,0.047619047619047616,0.0,0.0,P51654,Cancer
Undisclosed protein,0.047619047619047616,0.0,0.0,P51654,Cancer
WYE-130600,0.047619047619047616,0.0,0.0,P51654,Cancer
BIOO-1,0.047619047619047616,0.0,0.0,P51654,Cancer
PIROXANTRONE,0.047619047619047616,0.0,0.0,P51654,Cancer
HZ-08,0.047619047619047616,0.0,0.0,P51654,Cancer
BIOO-3,0.047619047619047616,0.0,0.0,P51654,Cancer
BIOO-2,0.047619047619047616,0.0,0.0,P51654,Cancer
BIOO-5,0.047619047619047616,0.0,0.0,P51654,Cancer
CARM1 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
LA-480,0.047619047619047616,0.0,0.0,P51654,Cancer
PKI-402,0.047619047619047616,0.0,0.0,P51654,Cancer
P-6915,0.047619047619047616,0.0,0.0,P51654,Cancer
LP-226A1,0.047619047619047616,0.0,0.0,P51654,Cancer
HD-148,0.047619047619047616,0.0,0.0,P51654,Cancer
JIN-2011,0.047619047619047616,0.0,0.0,P51654,Cancer
BIOO-6,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-4217903,0.047619047619047616,0.0,0.0,P51654,Cancer
EZN-4150,0.047619047619047616,0.0,0.0,P51654,Cancer
Orazamide orotate,0.047619047619047616,0.0,0.0,P51654,Cancer
TAK-733,0.047619047619047616,0.0,0.0,P51654,Cancer
DNA alkylating agents,0.047619047619047616,0.0,0.0,P51654,Cancer
CM-101,0.047619047619047616,0.0,0.0,P51654,Cancer
NC-0604,0.047619047619047616,0.0,0.0,P51654,Cancer
Vaccine; cancer; Wistar Institute of Anatomy & Biology,0.047619047619047616,0.0,0.0,P51654,Cancer
CP51-2705,0.047619047619047616,0.0,0.0,P51654,Cancer
MDX-1414,0.047619047619047616,0.0,0.0,P51654,Cancer
APH-0911,0.047619047619047616,0.0,0.0,P51654,Cancer
PHA-647A,0.047619047619047616,0.0,0.0,P51654,Cancer
MDX-1411,0.047619047619047616,0.0,0.0,P51654,Cancer
GD2 ganglioside peptide mimics,0.047619047619047616,0.0,0.0,P51654,Cancer
BL-1893,0.047619047619047616,0.0,0.0,P51654,Cancer
PNT-200,0.047619047619047616,0.0,0.0,P51654,Cancer
Synthetic peptide,0.047619047619047616,0.0,0.0,P51654,Cancer
213-Bi DOTA-PESIN,0.047619047619047616,0.0,0.0,P51654,Cancer
PBOX-15,0.047619047619047616,0.0,0.0,P51654,Cancer
CYT-6091,0.047619047619047616,0.0,0.0,P51654,Cancer
Metoprine,0.0,0.0,0.0,P51654,Advanced cancers
LG-1550,0.047619047619047616,0.0,0.0,P51654,Cancer
Apoptosis-inducing peptide,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY-86-9596,0.047619047619047616,0.0,0.0,P51654,Cancer
TT-310,0.047619047619047616,0.0,0.0,P51654,Cancer
CRL-37212,0.047619047619047616,0.0,0.0,P51654,Cancer
GSK-2256098,0.047619047619047616,0.0,0.0,P51654,Cancer
V-1810,0.047619047619047616,0.0,0.0,P51654,Cancer
ARQ-087,0.047619047619047616,0.0,0.0,P51654,Cancer
VEGFR3 Monoclonal Antibody,0.047619047619047616,0.0,0.0,P51654,Cancer
VPC-8,0.047619047619047616,0.0,0.0,P51654,Cancer
ABD-035,0.047619047619047616,0.0,0.0,P51654,Cancer
Del 60 tetramer,0.047619047619047616,0.0,0.0,P51654,Cancer
Inhaled supergeneric,0.047619047619047616,0.0,0.0,P51654,Cancer
Tr-3,0.047619047619047616,0.0,0.0,P51654,Cancer
Tr-2,0.047619047619047616,0.0,0.0,P51654,Cancer
HLM-008182,0.047619047619047616,0.0,0.0,P51654,Cancer
EM-6110a,0.047619047619047616,0.0,0.0,P51654,Cancer
BBI-608,0.047619047619047616,0.0,0.0,P51654,Cancer
GW-559768X,0.047619047619047616,0.0,0.0,P51654,Cancer
Botulinum toxin type A gel,0.047619047619047616,0.0,0.0,P51654,Cancer
MNLP-462a,0.047619047619047616,0.0,0.0,P51654,Cancer
APR-246,0.047619047619047616,0.0,0.0,P51654,Cancer
KYS-05050,0.047619047619047616,0.0,0.0,P51654,Cancer
SOM-0777,0.047619047619047616,0.0,0.0,P51654,Cancer
DWJ-424,0.047619047619047616,0.0,0.0,P51654,Cancer
REGN1400,0.047619047619047616,0.0,0.0,P51654,Cancer
VLI-03B,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
VEGF kinoid,0.047619047619047616,0.0,0.0,P51654,Cancer
XR-3054,0.047619047619047616,0.0,0.0,P51654,Cancer
AE-298p,0.047619047619047616,0.0,0.0,P51654,Cancer
SULOFENUR,0.047619047619047616,0.0,0.0,P51654,Cancer
SNG-163,0.047619047619047616,0.0,0.0,P51654,Cancer
CUV-3,0.047619047619047616,0.0,0.0,P51654,Cancer
HCBE-11,0.047619047619047616,0.0,0.0,P51654,Cancer
STAT-3 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
Deuteroporphyrin,0.047619047619047616,0.0,0.0,P51654,Cancer
WTC-01,0.047619047619047616,0.0,0.0,P51654,Cancer
IKH-02,0.047619047619047616,0.0,0.0,P51654,Cancer
PHY-777,0.047619047619047616,0.0,0.0,P51654,Cancer
RP-656,0.047619047619047616,0.0,0.0,P51654,Cancer
SX-RDS1,0.047619047619047616,0.0,0.0,P51654,Cancer
LC-445,0.047619047619047616,0.0,0.0,P51654,Cancer
ONYX-411,0.047619047619047616,0.0,0.0,P51654,Cancer
Armodafinil,0.047619047619047616,0.0,0.0,P51654,Cancer
ImmuneFx,0.047619047619047616,0.0,0.0,P51654,Cancer
BP-9906,0.047619047619047616,0.0,0.0,P51654,Cancer
DP-266,0.047619047619047616,0.0,0.0,P51654,Cancer
MAb therapy; cancer; Igenica,0.047619047619047616,0.0,0.0,P51654,Cancer
IKS-04,0.047619047619047616,0.0,0.0,P51654,Cancer
MVA-BN Brachyury,0.047619047619047616,0.0,0.0,P51654,Cancer
OSU-2S,0.047619047619047616,0.0,0.0,P51654,Cancer
CDP-845,0.047619047619047616,0.0,0.0,P51654,Cancer
AR-00341677,0.047619047619047616,0.0,0.0,P51654,Cancer
SMNT-1,0.047619047619047616,0.0,0.0,P51654,Cancer
CI-994,0.047619047619047616,0.0,0.0,P51654,Cancer
STF-31,0.047619047619047616,0.0,0.0,P51654,Cancer
F-14512,0.047619047619047616,0.0,0.0,P51654,Cancer
SAR-131675,0.047619047619047616,0.0,0.0,P51654,Cancer
BGB-283,0.047619047619047616,0.0,0.0,P51654,Cancer
CBI-006,0.047619047619047616,0.0,0.0,P51654,Cancer
CBI-008,0.047619047619047616,0.0,0.0,P51654,Cancer
R7112,0.047619047619047616,0.0,0.0,P51654,Cancer
Gemcitabine prodrug,0.047619047619047616,0.0,0.0,P51654,Cancer
KNW-001,0.047619047619047616,0.0,0.0,P51654,Cancer
Recombinant human endostatin,0.047619047619047616,0.0,0.0,P51654,Cancer
ERBULOZOLE,0.047619047619047616,0.0,0.0,P51654,Cancer
CIP-137401,0.047619047619047616,0.0,0.0,P51654,Cancer
Vascugel,0.047619047619047616,0.0,0.0,P51654,Cancer
PMX-900,0.047619047619047616,0.0,0.0,P51654,Cancer
227Th-trastuzumab (cancer); Algeta,0.047619047619047616,0.0,0.0,P51654,Cancer
EQ-818-1,0.047619047619047616,0.0,0.0,P51654,Cancer
IP-112,0.047619047619047616,0.0,0.0,P51654,Cancer
RON Monoclonal Antibody,0.047619047619047616,0.0,0.0,P51654,Cancer
Larotaxel,0.047619047619047616,0.0,0.0,P51654,Cancer
KaroMab,0.047619047619047616,0.0,0.0,P51654,Cancer
Cancer therapy; SP1,0.047619047619047616,0.0,0.0,P51654,Cancer
JIN-2019,0.047619047619047616,0.0,0.0,P51654,Cancer
Polymer-tubulysin A prodrug conjugate,0.047619047619047616,0.0,0.0,P51654,Cancer
SapC-DOPS,0.047619047619047616,0.0,0.0,P51654,Cancer
Medusa IL-2,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-hTfR IgG3-Av,0.047619047619047616,0.0,0.0,P51654,Cancer
TB-09,0.047619047619047616,0.0,0.0,P51654,Cancer
APS-001,0.047619047619047616,0.0,0.0,P51654,Cancer
API-31510,0.047619047619047616,0.0,0.0,P51654,Cancer
Denibulin,0.047619047619047616,0.0,0.0,P51654,Cancer
P2B-002,0.047619047619047616,0.0,0.0,P51654,Cancer
HMPL-002,0.047619047619047616,0.0,0.0,P51654,Cancer
STAT-3 DECOY (NSC-741763),0.047619047619047616,0.0,0.0,P51654,Cancer
P2B-003,0.047619047619047616,0.0,0.0,P51654,Cancer
P2B-004,0.047619047619047616,0.0,0.0,P51654,Cancer
OM-197-MP-AC,0.047619047619047616,0.0,0.0,P51654,Cancer
HTERT vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
Metaiodobenzylguanidine I-131,0.047619047619047616,0.0,0.0,P51654,Cancer
APIT,0.047619047619047616,0.0,0.0,P51654,Cancer
KI-0001,0.047619047619047616,0.0,0.0,P51654,Cancer
KI-0003,0.047619047619047616,0.0,0.0,P51654,Cancer
HOO-IFOS,0.047619047619047616,0.0,0.0,P51654,Cancer
HuMV833,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-miR-191 modified oligonucleotide,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
TSRI-265,0.047619047619047616,0.0,0.0,P51654,Cancer
CT-2412,0.047619047619047616,0.0,0.0,P51654,Cancer
PET imaging agent,0.047619047619047616,0.0,0.0,P51654,Cancer
[99mTc]Met,0.047619047619047616,0.0,0.0,P51654,Cancer
LY-2584702,0.047619047619047616,0.0,0.0,P51654,Cancer
18F-SMIBR-K5,0.047619047619047616,0.0,0.0,P51654,Cancer
L-745631,0.047619047619047616,0.0,0.0,P51654,Cancer
CCX-662,0.047619047619047616,0.0,0.0,P51654,Cancer
CYC-4068,0.047619047619047616,0.0,0.0,P51654,Cancer
212-Pb-TCMC-trastuzumab,0.047619047619047616,0.0,0.0,P51654,Cancer
Mutant ras vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
BGB-290,0.047619047619047616,0.0,0.0,P51654,Cancer
1069C,0.047619047619047616,0.0,0.0,P51654,Cancer
S-3304,0.047619047619047616,0.0,0.0,P51654,Cancer
PAN-22,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
Trametinib + 2141795,0.047619047619047616,0.0,0.0,P51654,Cancer
COG-112,0.047619047619047616,0.0,0.0,P51654,Cancer
SPVF-2801-10,0.047619047619047616,0.0,0.0,P51654,Cancer
LEURUBICIN,0.047619047619047616,0.0,0.0,P51654,Cancer
CTT-54,0.047619047619047616,0.0,0.0,P51654,Cancer
BVB-808,0.0,0.0,0.0,P51654,Pediatric cancer
HKI-46F08,0.047619047619047616,0.0,0.0,P51654,Cancer
ANG-2864,0.047619047619047616,0.0,0.0,P51654,Cancer
BAL-101553,0.047619047619047616,0.0,0.0,P51654,Cancer
Ecomustine,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-CD5 humanized mAb,0.047619047619047616,0.0,0.0,P51654,Cancer
LY2780301,0.047619047619047616,0.0,0.0,P51654,Cancer
PNT-600,0.047619047619047616,0.0,0.0,P51654,Cancer
REIC gene therapy,0.047619047619047616,0.0,0.0,P51654,Cancer
4SC-202,0.047619047619047616,0.0,0.0,P51654,Cancer
ASP9853,0.047619047619047616,0.0,0.0,P51654,Cancer
GR-ARA1,0.047619047619047616,0.0,0.0,P51654,Cancer
Berubicin,0.047619047619047616,0.0,0.0,P51654,Cancer
BU-32,0.047619047619047616,0.0,0.0,P51654,Cancer
P31-Protein,0.047619047619047616,0.0,0.0,P51654,Cancer
HS-113,0.047619047619047616,0.0,0.0,P51654,Cancer
VPC-51299,0.047619047619047616,0.0,0.0,P51654,Cancer
4SC-207,0.047619047619047616,0.0,0.0,P51654,Cancer
GF-15,0.047619047619047616,0.0,0.0,P51654,Cancer
LQB-118,0.047619047619047616,0.0,0.0,P51654,Cancer
Gadolinium based C60 fullerene-paclitaxel-ZME-018 conjugates,0.047619047619047616,0.0,0.0,P51654,Cancer
2-deoxyglucose,0.047619047619047616,0.0,0.0,P51654,Cancer
MK-8033,0.0,0.0,0.0,P51654,Advanced cancers
CHR-4125,0.047619047619047616,0.0,0.0,P51654,Cancer
Flavopiridol,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
XmAb 5574/MOR208,0.047619047619047616,0.0,0.0,P51654,Cancer
BN-108,0.047619047619047616,0.0,0.0,P51654,Cancer
PC-8608,0.047619047619047616,0.0,0.0,P51654,Cancer
IV aprepitant,0.047619047619047616,0.0,0.0,P51654,Cancer
Aurora A kinase inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
RESP-4000,0.0,0.0,0.0,P51654,Kidney cancer
Sensor linked micelle,0.047619047619047616,0.0,0.0,P51654,Cancer
Diazeniumdiolate NO releasing compounds,0.047619047619047616,0.0,0.0,P51654,Cancer
PFK-015,0.047619047619047616,0.0,0.0,P51654,Cancer
IVV-001,0.047619047619047616,0.0,0.0,P51654,Cancer
AVP-7,0.047619047619047616,0.0,0.0,P51654,Cancer
DVD-Ig,0.047619047619047616,0.0,0.0,P51654,Cancer
AL-6802,0.047619047619047616,0.0,0.0,P51654,Cancer
CA-01,0.047619047619047616,0.0,0.0,P51654,Cancer
AVP-4,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-182566,0.047619047619047616,0.0,0.0,P51654,Cancer
SGI-1252,0.047619047619047616,0.0,0.0,P51654,Cancer
LT-0301,0.047619047619047616,0.0,0.0,P51654,Cancer
CG-103065,0.047619047619047616,0.0,0.0,P51654,Cancer
LY-2780301,0.047619047619047616,0.0,0.0,P51654,Cancer
INO-1002,0.047619047619047616,0.0,0.0,P51654,Cancer
Tie-2 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
CURCUMIN,0.047619047619047616,0.0,0.0,P51654,Cancer
IMC-CS4,0.047619047619047616,0.0,0.0,P51654,Cancer
WBI-2000,0.047619047619047616,0.0,0.0,P51654,Cancer
APG-232,0.047619047619047616,0.0,0.0,P51654,Cancer
DT-320,0.047619047619047616,0.0,0.0,P51654,Cancer
MAbs targeting human growth hormone,0.047619047619047616,0.0,0.0,P51654,Cancer
B-581,0.047619047619047616,0.0,0.0,P51654,Cancer
Atpenin B,0.047619047619047616,0.0,0.0,P51654,Cancer
Paclitaxel,0.047619047619047616,0.0,0.0,P51654,Cancer
LFA-102,0.047619047619047616,0.0,0.0,P51654,Cancer
Personalized peptide vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
LY335979,0.047619047619047616,0.0,0.0,P51654,Cancer
BIND-014,0.047619047619047616,0.0,0.0,P51654,Cancer
KOS-2484,0.047619047619047616,0.0,0.0,P51654,Cancer
PMX-500,0.047619047619047616,0.0,0.0,P51654,Cancer
ARRY-575,0.047619047619047616,0.0,0.0,P51654,Cancer
DT-310,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-05212384,0.047619047619047616,0.0,0.0,P51654,Cancer
RG-7599,0.0,0.0,0.0,P51654,Ovarian cancer
Antineoplaston-A5,0.047619047619047616,0.0,0.0,P51654,Cancer
Antineoplaston-A3,0.047619047619047616,0.0,0.0,P51654,Cancer
KA-10X,0.047619047619047616,0.0,0.0,P51654,Cancer
Immunotherapeutic,0.047619047619047616,0.0,0.0,P51654,Cancer
LTX-315,0.047619047619047616,0.0,0.0,P51654,Cancer
Oncology therapeutics,0.047619047619047616,0.0,0.0,P51654,Cancer
ALERT,0.047619047619047616,0.0,0.0,P51654,Cancer
Debio-0826,0.047619047619047616,0.0,0.0,P51654,Cancer
PHA-665752,0.047619047619047616,0.0,0.0,P51654,Cancer
LY2835219,0.047619047619047616,0.0,0.0,P51654,Cancer
NHS-IL 12,0.047619047619047616,0.0,0.0,P51654,Cancer
DW-167,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
ANG-1007,0.047619047619047616,0.0,0.0,P51654,Cancer
Triciribine prodrug,0.047619047619047616,0.0,0.0,P51654,Cancer
Small-molecule cetuximab binding mimics,0.047619047619047616,0.0,0.0,P51654,Cancer
AGS-8M4,0.047619047619047616,0.0,0.0,P51654,Cancer
Tolonium chloride,0.047619047619047616,0.0,0.0,P51654,Cancer
GIT27-NO,0.047619047619047616,0.0,0.0,P51654,Cancer
Nanotherapeutics,0.047619047619047616,0.0,0.0,P51654,Cancer
HBI-8000,0.047619047619047616,0.0,0.0,P51654,Cancer
UltiMAb IgG1 antibody,0.047619047619047616,0.0,0.0,P51654,Cancer
APG-201,0.047619047619047616,0.0,0.0,P51654,Cancer
NSC-281612,0.047619047619047616,0.0,0.0,P51654,Cancer
SST-0001,0.047619047619047616,0.0,0.0,P51654,Cancer
Cripto-1 mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
TS antisense + 5-FU,0.047619047619047616,0.0,0.0,P51654,Cancer
CEN-109,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-Fas mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
Salmonella typhimurium A1-R,0.047619047619047616,0.0,0.0,P51654,Cancer
LLL-12,0.047619047619047616,0.0,0.0,P51654,Cancer
WP-1066,0.047619047619047616,0.0,0.0,P51654,Cancer
VLI-01B,0.047619047619047616,0.0,0.0,P51654,Cancer
GDC-0199,0.047619047619047616,0.0,0.0,P51654,Cancer
ARRY-520,0.047619047619047616,0.0,0.0,P51654,Cancer
D-11B,0.047619047619047616,0.0,0.0,P51654,Cancer
BN-AM-206,0.047619047619047616,0.0,0.0,P51654,Cancer
MTX-25251,0.047619047619047616,0.0,0.0,P51654,Cancer
CT-400,0.047619047619047616,0.0,0.0,P51654,Cancer
CDP-850,0.047619047619047616,0.0,0.0,P51654,Cancer
P1446A-05,0.047619047619047616,0.0,0.0,P51654,Cancer
Adva-R46,0.047619047619047616,0.0,0.0,P51654,Cancer
Cancer Vac,0.047619047619047616,0.0,0.0,P51654,Cancer
LANIQUIDAR,0.047619047619047616,0.0,0.0,P51654,Cancer
MiRNA targeting agent,0.047619047619047616,0.0,0.0,P51654,Cancer
A35566-A,0.047619047619047616,0.0,0.0,P51654,Cancer
HLA-A; B7.1-transfected adenocarcinoma vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
IKH-25,0.047619047619047616,0.0,0.0,P51654,Cancer
ALM-301,0.047619047619047616,0.0,0.0,P51654,Cancer
J-30,0.047619047619047616,0.0,0.0,P51654,Cancer
DCR-MYC,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
Cancer therapy; Carigent Therapeutics Inc,0.047619047619047616,0.0,0.0,P51654,Cancer
P54,0.047619047619047616,0.0,0.0,P51654,Cancer
P53,0.047619047619047616,0.0,0.0,P51654,Cancer
EG-Vac,0.047619047619047616,0.0,0.0,P51654,Cancer
Smoothened receptor antagonist,0.047619047619047616,0.0,0.0,P51654,Cancer
Buthionine sulfoximine,0.047619047619047616,0.0,0.0,P51654,Cancer
ISIS-EIF4ERx,0.047619047619047616,0.0,0.0,P51654,Cancer
HLL1-Fab-A3B3,0.047619047619047616,0.0,0.0,P51654,Cancer
CEP-28122,0.047619047619047616,0.0,0.0,P51654,Cancer
Cancer therapy; ProXara Biotechnology Ltd,0.047619047619047616,0.0,0.0,P51654,Cancer
TAK-701,0.0,0.0,0.0,P51654,Advanced malignancies
PJJ-34,0.047619047619047616,0.0,0.0,P51654,Cancer
MG-28,0.047619047619047616,0.0,0.0,P51654,Cancer
AV-370,0.047619047619047616,0.0,0.0,P51654,Cancer
Irofulven/Taxotere,0.047619047619047616,0.0,0.0,P51654,Cancer
PGGA-PTX,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-4554878,0.047619047619047616,0.0,0.0,P51654,Cancer
DI-VAL-L-DC,0.047619047619047616,0.0,0.0,P51654,Cancer
Diethylstilbestrol,0.047619047619047616,0.0,0.0,P51654,Cancer
PDM-08,0.047619047619047616,0.0,0.0,P51654,Cancer
Soblidotin,0.047619047619047616,0.0,0.0,P51654,Cancer
SGX201,0.047619047619047616,0.0,0.0,P51654,Cancer
OC42-92,0.047619047619047616,0.0,0.0,P51654,Cancer
SCH-1450206,0.047619047619047616,0.0,0.0,P51654,Cancer
Encepur,0.0,0.0,0.0,P51654,Pediatric cancer
Recombinant Wolinella (rWS) asparaginase,0.047619047619047616,0.0,0.0,P51654,Cancer
EP-400,0.047619047619047616,0.0,0.0,P51654,Cancer
Nitric Oxide,0.047619047619047616,0.0,0.0,P51654,Cancer
MTL-003,0.047619047619047616,0.0,0.0,P51654,Cancer
SJ-8002,0.047619047619047616,0.0,0.0,P51654,Cancer
MTL-007,0.047619047619047616,0.0,0.0,P51654,Cancer
MTL-005,0.047619047619047616,0.0,0.0,P51654,Cancer
MTL-004,0.047619047619047616,0.0,0.0,P51654,Cancer
B-956,0.047619047619047616,0.0,0.0,P51654,Cancer
GX-G3,0.047619047619047616,0.0,0.0,P51654,Cancer
PQ-1,0.047619047619047616,0.0,0.0,P51654,Cancer
SB-743921,0.047619047619047616,0.0,0.0,P51654,Cancer
ProLindaun,0.047619047619047616,0.0,0.0,P51654,Cancer
ABT-627,0.047619047619047616,0.0,0.0,P51654,Cancer
CSP-9222,0.047619047619047616,0.0,0.0,P51654,Cancer
CB3304,0.047619047619047616,0.0,0.0,P51654,Cancer
WAY-255348,0.047619047619047616,0.0,0.0,P51654,Cancer
QBI-206,0.047619047619047616,0.0,0.0,P51654,Cancer
AN-207,0.047619047619047616,0.0,0.0,P51654,Cancer
ICGD,0.047619047619047616,0.0,0.0,P51654,Cancer
N-885,0.047619047619047616,0.0,0.0,P51654,Cancer
Tasidotin hydrochloride,0.047619047619047616,0.0,0.0,P51654,Cancer
PYN-7,0.047619047619047616,0.0,0.0,P51654,Cancer
IMP-701,0.047619047619047616,0.0,0.0,P51654,Cancer
TH-1320,0.047619047619047616,0.0,0.0,P51654,Cancer
BAL-27862,0.047619047619047616,0.0,0.0,P51654,Cancer
6F4,0.047619047619047616,0.0,0.0,P51654,Cancer
AVI4126,0.047619047619047616,0.0,0.0,P51654,Cancer
BGJ398,0.047619047619047616,0.0,0.0,P51654,Cancer
CRYPTOPHYCIN 52,0.047619047619047616,0.0,0.0,P51654,Cancer
Vinflunine,0.047619047619047616,0.0,0.0,P51654,Cancer
Sepimostat mesylate,0.047619047619047616,0.0,0.0,P51654,Cancer
CP-663427,0.047619047619047616,0.0,0.0,P51654,Cancer
Endovion,0.047619047619047616,0.0,0.0,P51654,Cancer
APN-501,0.047619047619047616,0.0,0.0,P51654,Cancer
NSC-639829,0.047619047619047616,0.0,0.0,P51654,Cancer
NMS-1,0.047619047619047616,0.0,0.0,P51654,Cancer
Mycobacterial cell wall-DNA complex,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-GD2 mAb,0.047619047619047616,0.0,0.0,P51654,Cancer
CCT-241533,0.047619047619047616,0.0,0.0,P51654,Cancer
Pim1 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
E12/DP3-117,0.047619047619047616,0.0,0.0,P51654,Cancer
Drug 2849330,0.047619047619047616,0.0,0.0,P51654,Cancer
Evatak,0.047619047619047616,0.0,0.0,P51654,Cancer
PRI-724,0.047619047619047616,0.0,0.0,P51654,Cancer
GivaRex,0.047619047619047616,0.0,0.0,P51654,Cancer
P-3378,0.047619047619047616,0.0,0.0,P51654,Cancer
MVA E2 vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
Multi-targeted therapeutics,0.047619047619047616,0.0,0.0,P51654,Cancer
KI-0804,0.047619047619047616,0.0,0.0,P51654,Cancer
KI-0803,0.047619047619047616,0.0,0.0,P51654,Cancer
LP-10218,0.047619047619047616,0.0,0.0,P51654,Cancer
T-oligos,0.047619047619047616,0.0,0.0,P51654,Cancer
TG-4023,0.047619047619047616,0.0,0.0,P51654,Cancer
FCE-28161,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-PrP mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
AMG-429,0.047619047619047616,0.0,0.0,P51654,Cancer
AZ-05,0.047619047619047616,0.0,0.0,P51654,Cancer
Rhenex,0.047619047619047616,0.0,0.0,P51654,Cancer
CC-11006,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-FGFR2 humanized mAb,0.047619047619047616,0.0,0.0,P51654,Cancer
DT-330,0.047619047619047616,0.0,0.0,P51654,Cancer
Recombinant interleukin-2,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1438,0.047619047619047616,0.0,0.0,P51654,Cancer
OXA-01,0.047619047619047616,0.0,0.0,P51654,Cancer
PVX-410,0.047619047619047616,0.0,0.0,P51654,Cancer
IRISQUINONE,0.047619047619047616,0.0,0.0,P51654,Cancer
Targeted ranpirnase conjugates,0.047619047619047616,0.0,0.0,P51654,Cancer
1D09C3,0.047619047619047616,0.0,0.0,P51654,Cancer
Pretubulysin,0.047619047619047616,0.0,0.0,P51654,Cancer
HER2p63-71 peptide vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
DTS-108,0.047619047619047616,0.0,0.0,P51654,Cancer
SPL-2101,0.047619047619047616,0.0,0.0,P51654,Cancer
PRT6207,0.047619047619047616,0.0,0.0,P51654,Cancer
KU-135,0.047619047619047616,0.0,0.0,P51654,Cancer
Bivatuzumab mertansine,0.047619047619047616,0.0,0.0,P51654,Cancer
Sophorolipid isoforms,0.047619047619047616,0.0,0.0,P51654,Cancer
U3-1565,0.047619047619047616,0.0,0.0,P51654,Cancer
RP-1040,0.047619047619047616,0.0,0.0,P51654,Cancer
CP-547632,0.047619047619047616,0.0,0.0,P51654,Cancer
PI-88,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
AMG 232,0.047619047619047616,0.0,0.0,P51654,Cancer
AZ-23,0.047619047619047616,0.0,0.0,P51654,Cancer
KYN-54,0.047619047619047616,0.0,0.0,P51654,Cancer
Autologous melanoma cell vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
ZSTK474,0.047619047619047616,0.0,0.0,P51654,Cancer
TCR-transduced T-cell immunotherapy,0.047619047619047616,0.0,0.0,P51654,Cancer
Omniferon,0.047619047619047616,0.0,0.0,P51654,Cancer
IPP-204106,0.047619047619047616,0.0,0.0,P51654,Cancer
RO-09-4889,0.047619047619047616,0.0,0.0,P51654,Cancer
4-IPP,0.047619047619047616,0.0,0.0,P51654,Cancer
RP-701,0.047619047619047616,0.0,0.0,P51654,Cancer
18F-VEGF binding peptides (PET imaging); Genentech,0.047619047619047616,0.0,0.0,P51654,Cancer
AZD-6495,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1246,0.047619047619047616,0.0,0.0,P51654,Cancer
GlycoPEG-GCSF,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1245,0.047619047619047616,0.0,0.0,P51654,Cancer
OB-24,0.047619047619047616,0.0,0.0,P51654,Cancer
ABT-806,0.047619047619047616,0.0,0.0,P51654,Cancer
CX-7000,0.047619047619047616,0.0,0.0,P51654,Cancer
CEP-32496,0.047619047619047616,0.0,0.0,P51654,Cancer
99mTc-Hynic-Annexin V,0.047619047619047616,0.0,0.0,P51654,Cancer
Peg-G-CSF,0.047619047619047616,0.0,0.0,P51654,Cancer
MPC-2130,0.047619047619047616,0.0,0.0,P51654,Cancer
IGN301,0.047619047619047616,0.0,0.0,P51654,Cancer
IMC-1C11,0.047619047619047616,0.0,0.0,P51654,Cancer
LY2874455,0.047619047619047616,0.0,0.0,P51654,Cancer
SB-2280,0.047619047619047616,0.0,0.0,P51654,Cancer
NBM-HD-1,0.047619047619047616,0.0,0.0,P51654,Cancer
HC-15,0.047619047619047616,0.0,0.0,P51654,Cancer
GLG-101,0.047619047619047616,0.0,0.0,P51654,Cancer
Cytoreg,0.047619047619047616,0.0,0.0,P51654,Cancer
BIM-26226,0.047619047619047616,0.0,0.0,P51654,Cancer
Anticancer Therapy; Endo,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-03772304,0.047619047619047616,0.0,0.0,P51654,Cancer
BPR1K-0224,0.047619047619047616,0.0,0.0,P51654,Cancer
D-20133,0.047619047619047616,0.0,0.0,P51654,Cancer
EDP-17,0.047619047619047616,0.0,0.0,P51654,Cancer
W-198,0.047619047619047616,0.0,0.0,P51654,Cancer
YK-3237,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1226,0.047619047619047616,0.0,0.0,P51654,Cancer
LY-2624587,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1220,0.047619047619047616,0.0,0.0,P51654,Cancer
UAI-201,0.047619047619047616,0.0,0.0,P51654,Cancer
IDN-13389,0.047619047619047616,0.0,0.0,P51654,Cancer
ZIO-102,0.047619047619047616,0.0,0.0,P51654,Cancer
RTA-301,0.047619047619047616,0.0,0.0,P51654,Cancer
ETS-2101,0.047619047619047616,0.0,0.0,P51654,Cancer
Giracodazole,0.047619047619047616,0.0,0.0,P51654,Cancer
PAT-CM-1,0.047619047619047616,0.0,0.0,P51654,Cancer
EDP-20,0.047619047619047616,0.0,0.0,P51654,Cancer
Small molecule 19a,0.047619047619047616,0.0,0.0,P51654,Cancer
EDP-24,0.047619047619047616,0.0,0.0,P51654,Cancer
LY-2875358,0.047619047619047616,0.0,0.0,P51654,Cancer
GM-CT-01,0.047619047619047616,0.0,0.0,P51654,Cancer
ABI-013,0.047619047619047616,0.0,0.0,P51654,Cancer
C3086120],0.047619047619047616,0.0,0.0,P51654,Cancer
PAT-NM-1,0.047619047619047616,0.0,0.0,P51654,Cancer
EDP-08,0.047619047619047616,0.0,0.0,P51654,Cancer
ABI-011,0.047619047619047616,0.0,0.0,P51654,Cancer
AZD5363,0.047619047619047616,0.0,0.0,P51654,Cancer
V930,0.047619047619047616,0.0,0.0,P51654,Cancer
CVA-21 DAF,0.047619047619047616,0.0,0.0,P51654,Cancer
JNJ-26483327,0.047619047619047616,0.0,0.0,P51654,Cancer
FO-152,0.047619047619047616,0.0,0.0,P51654,Cancer
Antiparasitics,0.047619047619047616,0.0,0.0,P51654,Cancer
OMN-54,0.047619047619047616,0.0,0.0,P51654,Cancer
Citatuzumab bogatox,0.047619047619047616,0.0,0.0,P51654,Cancer
AugmAb,0.047619047619047616,0.0,0.0,P51654,Cancer
HPP-607,0.047619047619047616,0.0,0.0,P51654,Cancer
Alpha-C-galactosyl ceramide,0.047619047619047616,0.0,0.0,P51654,Cancer
SUPER-LEU-DOX,0.047619047619047616,0.0,0.0,P51654,Cancer
LB-100,0.047619047619047616,0.0,0.0,P51654,Cancer
Second generation taxoids,0.0,0.0,0.0,P51654,Kidney cancer
PF-4383119,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
Small molecule 18a,0.047619047619047616,0.0,0.0,P51654,Cancer
EDP-13,0.047619047619047616,0.0,0.0,P51654,Cancer
RBBX-01,0.0,0.0,0.0,P51654,Pediatric cancer
BhCG vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
AST-1306,0.047619047619047616,0.0,0.0,P51654,Cancer
C-5304,0.047619047619047616,0.0,0.0,P51654,Cancer
CUDC-907,0.047619047619047616,0.0,0.0,P51654,Cancer
Sch-49209,0.047619047619047616,0.0,0.0,P51654,Cancer
ZD-6126,0.047619047619047616,0.0,0.0,P51654,Cancer
ZP-2571,0.047619047619047616,0.0,0.0,P51654,Cancer
IDN-6439,0.047619047619047616,0.0,0.0,P51654,Cancer
HuCAL-derived fully human antibodies,0.047619047619047616,0.0,0.0,P51654,Cancer
L-731735,0.047619047619047616,0.0,0.0,P51654,Cancer
Sch-49210,0.047619047619047616,0.0,0.0,P51654,Cancer
Conjugated-trastuzumab,0.047619047619047616,0.0,0.0,P51654,Cancer
RX-1792,0.047619047619047616,0.0,0.0,P51654,Cancer
DNA fusion vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
CX-99,0.047619047619047616,0.0,0.0,P51654,Cancer
LY-2228820,0.047619047619047616,0.0,0.0,P51654,Cancer
VL-01,0.047619047619047616,0.0,0.0,P51654,Cancer
Onco-D,0.047619047619047616,0.0,0.0,P51654,Cancer
Artemisinin-based iron chelators,0.047619047619047616,0.0,0.0,P51654,Cancer
XL-888,0.047619047619047616,0.0,0.0,P51654,Cancer
BBI-8000,0.047619047619047616,0.0,0.0,P51654,Cancer
G-573,0.047619047619047616,0.0,0.0,P51654,Cancer
LY2812176,0.047619047619047616,0.0,0.0,P51654,Cancer
Batabulin,0.047619047619047616,0.0,0.0,P51654,Cancer
Oral peptide cancer vaccine,0.0,0.0,0.0,P51654,Pediatric cancer
SL-052,0.047619047619047616,0.0,0.0,P51654,Cancer
PI-88/Taxotere,0.047619047619047616,0.0,0.0,P51654,Cancer
SYM-007,0.047619047619047616,0.0,0.0,P51654,Cancer
Lexacalcitol,0.047619047619047616,0.0,0.0,P51654,Cancer
DNX-3000,0.047619047619047616,0.0,0.0,P51654,Cancer
IB-MECA,0.047619047619047616,0.0,0.0,P51654,Cancer
Dual Pgp/MRP1 inhibitors; Xenova,0.047619047619047616,0.0,0.0,P51654,Cancer
KU-2285,0.047619047619047616,0.0,0.0,P51654,Cancer
ADMDD-15,0.047619047619047616,0.0,0.0,P51654,Cancer
ATX-S10,0.047619047619047616,0.0,0.0,P51654,Cancer
IMD-026260,0.047619047619047616,0.0,0.0,P51654,Cancer
EndoAngio-GT,0.047619047619047616,0.0,0.0,P51654,Cancer
Vivia-007,0.047619047619047616,0.0,0.0,P51654,Cancer
Vivia-008,0.047619047619047616,0.0,0.0,P51654,Cancer
Vivia-009,0.047619047619047616,0.0,0.0,P51654,Cancer
SYM-005,0.047619047619047616,0.0,0.0,P51654,Cancer
FGFR2-ADC,0.047619047619047616,0.0,0.0,P51654,Cancer
SI-657,0.047619047619047616,0.0,0.0,P51654,Cancer
Jak2 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
EC0225,0.047619047619047616,0.0,0.0,P51654,Cancer
Fibrovax,0.047619047619047616,0.0,0.0,P51654,Cancer
Non-anticoagulation heparins,0.047619047619047616,0.0,0.0,P51654,Cancer
Adarotene ester derivative back-up compounds,0.047619047619047616,0.0,0.0,P51654,Cancer
Recombinant human Erbb3 fragment therapeutic tumor vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
Dicer-substrate small interfering RNAs,0.047619047619047616,0.0,0.0,P51654,Cancer
Hexyl aminolevulinate,0.047619047619047616,0.0,0.0,P51654,Cancer
Zinc finger protein transcripition factors,0.047619047619047616,0.0,0.0,P51654,Cancer
JNJ-26481585,0.047619047619047616,0.0,0.0,P51654,Cancer
MEN-14295,0.047619047619047616,0.0,0.0,P51654,Cancer
OB-28,0.047619047619047616,0.0,0.0,P51654,Cancer
GlycoPEGylated erythropoietin,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY1179470,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-04449913,0.047619047619047616,0.0,0.0,P51654,Cancer
SYM-011,0.047619047619047616,0.0,0.0,P51654,Cancer
PNT-300,0.047619047619047616,0.0,0.0,P51654,Cancer
IAI-100,0.047619047619047616,0.0,0.0,P51654,Cancer
BO-0742,0.047619047619047616,0.0,0.0,P51654,Cancer
PEGylated recombinant IFN-alpha2b,0.047619047619047616,0.0,0.0,P51654,Cancer
LEQ-506,0.047619047619047616,0.0,0.0,P51654,Cancer
EP-128504,0.047619047619047616,0.0,0.0,P51654,Cancer
LY-203725,0.047619047619047616,0.0,0.0,P51654,Cancer
SNS-314 prodrugs,0.047619047619047616,0.0,0.0,P51654,Cancer
Ellipravin,0.047619047619047616,0.0,0.0,P51654,Cancer
Ralimetinib,0.047619047619047616,0.0,0.0,P51654,Cancer
HL-146,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY-86-4367,0.047619047619047616,0.0,0.0,P51654,Cancer
ColoAd1,0.047619047619047616,0.0,0.0,P51654,Cancer
NOD factors,0.047619047619047616,0.0,0.0,P51654,Cancer
XR-5118,0.047619047619047616,0.0,0.0,P51654,Cancer
DAF-3,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-Her-2 mAb,0.047619047619047616,0.0,0.0,P51654,Cancer
AstraStim,0.047619047619047616,0.0,0.0,P51654,Cancer
Cell therapies,0.047619047619047616,0.0,0.0,P51654,Cancer
SA3C,0.047619047619047616,0.0,0.0,P51654,Cancer
REACTA,0.047619047619047616,0.0,0.0,P51654,Cancer
Tridolgosir,0.047619047619047616,0.0,0.0,P51654,Cancer
Saliphenylhalamide,0.047619047619047616,0.0,0.0,P51654,Cancer
KM-3900,0.047619047619047616,0.0,0.0,P51654,Cancer
PYZD-4409,0.047619047619047616,0.0,0.0,P51654,Cancer
EF-13,0.047619047619047616,0.0,0.0,P51654,Cancer
V-934/V-935,0.047619047619047616,0.0,0.0,P51654,Cancer
HL-1172,0.047619047619047616,0.0,0.0,P51654,Cancer
Nh-125,0.047619047619047616,0.0,0.0,P51654,Cancer
S-111,0.047619047619047616,0.0,0.0,P51654,Cancer
MSC2156119,0.047619047619047616,0.0,0.0,P51654,Cancer
HTERT plasmid DNA cancer vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
ISIS-STAT3Rx,0.047619047619047616,0.0,0.0,P51654,Cancer
SGN-30,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-05094037,0.047619047619047616,0.0,0.0,P51654,Cancer
BT-D005,0.047619047619047616,0.0,0.0,P51654,Cancer
HL-160,0.047619047619047616,0.0,0.0,P51654,Cancer
PHY-626,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-06650808,0.047619047619047616,0.0,0.0,P51654,Cancer
INX-3280,0.047619047619047616,0.0,0.0,P51654,Cancer
CC-0651,0.047619047619047616,0.0,0.0,P51654,Cancer
TAK-285,0.047619047619047616,0.0,0.0,P51654,Cancer
Antiangiogenic Surrobodies,0.047619047619047616,0.0,0.0,P51654,Cancer
ALL-3,0.047619047619047616,0.0,0.0,P51654,Cancer
MDC-917,0.047619047619047616,0.0,0.0,P51654,Cancer
Pyridocarbazole,0.047619047619047616,0.0,0.0,P51654,Cancer
APC-0010,0.047619047619047616,0.0,0.0,P51654,Cancer
CT-322,0.047619047619047616,0.0,0.0,P51654,Cancer
DZ-13,0.047619047619047616,0.0,0.0,P51654,Cancer
APC-0013,0.047619047619047616,0.0,0.0,P51654,Cancer
EC-154,0.047619047619047616,0.0,0.0,P51654,Cancer
BIBW-22,0.047619047619047616,0.0,0.0,P51654,Cancer
K-454,0.047619047619047616,0.0,0.0,P51654,Cancer
Vapreotide acetate,0.047619047619047616,0.0,0.0,P51654,Cancer
TRAIL-R Atrimer,0.047619047619047616,0.0,0.0,P51654,Cancer
Crisnatol,0.047619047619047616,0.0,0.0,P51654,Cancer
MDC-922,0.047619047619047616,0.0,0.0,P51654,Cancer
Interferon beta,0.047619047619047616,0.0,0.0,P51654,Cancer
NY-ESO-1 vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
IDN-5174,0.047619047619047616,0.0,0.0,P51654,Cancer
OM-174,0.047619047619047616,0.0,0.0,P51654,Cancer
Lpathomab,0.047619047619047616,0.0,0.0,P51654,Cancer
DOLASTATIN-10,0.047619047619047616,0.0,0.0,P51654,Cancer
CX-02,0.047619047619047616,0.0,0.0,P51654,Cancer
RHAMLET,0.047619047619047616,0.0,0.0,P51654,Cancer
ANA-011,0.047619047619047616,0.0,0.0,P51654,Cancer
SC-102,0.047619047619047616,0.0,0.0,P51654,Cancer
XL-499,0.047619047619047616,0.0,0.0,P51654,Cancer
ImBryon,0.047619047619047616,0.0,0.0,P51654,Cancer
LD-101,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY-85-3474,0.047619047619047616,0.0,0.0,P51654,Cancer
Kevetrin,0.047619047619047616,0.0,0.0,P51654,Cancer
CB1954,0.047619047619047616,0.0,0.0,P51654,Cancer
ARC-200,0.047619047619047616,0.0,0.0,P51654,Cancer
NDC-1022,0.047619047619047616,0.0,0.0,P51654,Cancer
BVD-523,0.047619047619047616,0.0,0.0,P51654,Cancer
AEH-10p,0.047619047619047616,0.0,0.0,P51654,Cancer
KST-213,0.047619047619047616,0.0,0.0,P51654,Cancer
CB-24,0.047619047619047616,0.0,0.0,P51654,Cancer
VGX-200,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-RON receptor mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
MLN4924,0.0,0.0,0.0,P51654,Advanced malignancies
Anti-HER-2 mAb-FcgR2- FcgR4 fusion proteins,0.047619047619047616,0.0,0.0,P51654,Cancer
Cytarabine ocfosfate,0.047619047619047616,0.0,0.0,P51654,Cancer
TTL-1177,0.047619047619047616,0.0,0.0,P51654,Cancer
T-cell therapy,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-06664178,0.047619047619047616,0.0,0.0,P51654,Cancer
PNH-192,0.047619047619047616,0.0,0.0,P51654,Cancer
LP-2307,0.047619047619047616,0.0,0.0,P51654,Cancer
GSK2849330,0.047619047619047616,0.0,0.0,P51654,Cancer
SDZ-280-446,0.047619047619047616,0.0,0.0,P51654,Cancer
LK-410,0.047619047619047616,0.0,0.0,P51654,Cancer
GPC-3298306,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
HSV-1716,0.047619047619047616,0.0,0.0,P51654,Cancer
BIWA 4,0.047619047619047616,0.0,0.0,P51654,Cancer
ISIS 13920,0.047619047619047616,0.0,0.0,P51654,Cancer
Merestinib; LY2801653,0.047619047619047616,0.0,0.0,P51654,Cancer
ARQ 621,0.047619047619047616,0.0,0.0,P51654,Cancer
MP-529,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-936564,0.047619047619047616,0.0,0.0,P51654,Cancer
Dofequidar fumarate,0.047619047619047616,0.0,0.0,P51654,Cancer
IMP-111,0.047619047619047616,0.0,0.0,P51654,Cancer
Dexniguldipine,0.047619047619047616,0.0,0.0,P51654,Cancer
NXD-30001,0.047619047619047616,0.0,0.0,P51654,Cancer
AGS-16M8F,0.047619047619047616,0.0,0.0,P51654,Cancer
CP-79328,0.047619047619047616,0.0,0.0,P51654,Cancer
ON-044580,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-00614435,0.047619047619047616,0.0,0.0,P51654,Cancer
SGN-10,0.047619047619047616,0.0,0.0,P51654,Cancer
MDP-01,0.047619047619047616,0.0,0.0,P51654,Cancer
AT-009,0.047619047619047616,0.0,0.0,P51654,Cancer
AT-006,0.047619047619047616,0.0,0.0,P51654,Cancer
AT-004,0.047619047619047616,0.0,0.0,P51654,Cancer
AT-003,0.047619047619047616,0.0,0.0,P51654,Cancer
ISF-120,0.047619047619047616,0.0,0.0,P51654,Cancer
Apomab,0.047619047619047616,0.0,0.0,P51654,Cancer
AT-001,0.047619047619047616,0.0,0.0,P51654,Cancer
Calcium nanoparticles,0.047619047619047616,0.0,0.0,P51654,Cancer
Enkastim-ev,0.047619047619047616,0.0,0.0,P51654,Cancer
ALD-805,0.047619047619047616,0.0,0.0,P51654,Cancer
KRH-102053,0.047619047619047616,0.0,0.0,P51654,Cancer
DNA intercalators,0.047619047619047616,0.0,0.0,P51654,Cancer
ALD-806,0.047619047619047616,0.0,0.0,P51654,Cancer
V930/V932,0.047619047619047616,0.0,0.0,P51654,Cancer
MK-0646,0.047619047619047616,0.0,0.0,P51654,Cancer
KW-2478,0.047619047619047616,0.0,0.0,P51654,Cancer
RG7212,0.047619047619047616,0.0,0.0,P51654,Cancer
MPC-0767,0.047619047619047616,0.0,0.0,P51654,Cancer
TPI-273,0.047619047619047616,0.0,0.0,P51654,Cancer
AT-012,0.047619047619047616,0.0,0.0,P51654,Cancer
S-1286,0.047619047619047616,0.0,0.0,P51654,Cancer
Liposome Encapsulated Mitoxantrone (LEM),0.047619047619047616,0.0,0.0,P51654,Cancer
FARANOXI,0.047619047619047616,0.0,0.0,P51654,Cancer
NMS-E973,0.047619047619047616,0.0,0.0,P51654,Cancer
Low toxic paclitaxel derivative,0.047619047619047616,0.0,0.0,P51654,Cancer
Ergotidine,0.047619047619047616,0.0,0.0,P51654,Cancer
RG7686,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
Multivalent carbohydrate-based vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
MB-312,0.047619047619047616,0.0,0.0,P51654,Cancer
MB-314,0.047619047619047616,0.0,0.0,P51654,Cancer
AT-027,0.047619047619047616,0.0,0.0,P51654,Cancer
Cytorex-EBV,0.047619047619047616,0.0,0.0,P51654,Cancer
Dismutase mimetics,0.047619047619047616,0.0,0.0,P51654,Cancer
MB-311,0.047619047619047616,0.0,0.0,P51654,Cancer
CMET Avimer polypeptides,0.047619047619047616,0.0,0.0,P51654,Cancer
GM-CSF cancer vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
Debio-0929,0.047619047619047616,0.0,0.0,P51654,Cancer
SER-207,0.047619047619047616,0.0,0.0,P51654,Cancer
DORANIDAZOLE,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-Neu5Gc mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
SER-203,0.047619047619047616,0.0,0.0,P51654,Cancer
SER-201,0.047619047619047616,0.0,0.0,P51654,Cancer
8-chloro-adenosine,0.047619047619047616,0.0,0.0,P51654,Cancer
Autologous dendritic cell vaccines,0.047619047619047616,0.0,0.0,P51654,Cancer
Trunkamide,0.047619047619047616,0.0,0.0,P51654,Cancer
2-deoxy-D-glucose,0.047619047619047616,0.0,0.0,P51654,Cancer
PSP-D-CD40L,0.047619047619047616,0.0,0.0,P51654,Cancer
ON 019190.Na,0.047619047619047616,0.0,0.0,P51654,Cancer
Miproxifene,0.047619047619047616,0.0,0.0,P51654,Cancer
CG-200745,0.047619047619047616,0.0,0.0,P51654,Cancer
CNX-1351,0.047619047619047616,0.0,0.0,P51654,Cancer
ICA-1,0.047619047619047616,0.0,0.0,P51654,Cancer
CPH-102,0.047619047619047616,0.0,0.0,P51654,Cancer
R-84,0.047619047619047616,0.0,0.0,P51654,Cancer
XL-388,0.047619047619047616,0.0,0.0,P51654,Cancer
FR-182877,0.047619047619047616,0.0,0.0,P51654,Cancer
Liposomal disintergrin,0.047619047619047616,0.0,0.0,P51654,Cancer
Cytotropic heterogeneous molecular lipids,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-3823863,0.047619047619047616,0.0,0.0,P51654,Cancer
Enkastim-iv,0.047619047619047616,0.0,0.0,P51654,Cancer
N-acetylardeemin,0.047619047619047616,0.0,0.0,P51654,Cancer
AP-10295,0.047619047619047616,0.0,0.0,P51654,Cancer
68Ga-DOTA-AE-105,0.047619047619047616,0.0,0.0,P51654,Cancer
LY2275796,0.0,0.0,0.0,P51654,Advanced cancers
AS-1406,0.047619047619047616,0.0,0.0,P51654,Cancer
HAP aniline mustard,0.047619047619047616,0.0,0.0,P51654,Cancer
SDZ-62-826,0.047619047619047616,0.0,0.0,P51654,Cancer
RON mAb,0.047619047619047616,0.0,0.0,P51654,Cancer
MPC-9528,0.047619047619047616,0.0,0.0,P51654,Cancer
SMOi2-17,0.047619047619047616,0.0,0.0,P51654,Cancer
AD-0027,0.047619047619047616,0.0,0.0,P51654,Cancer
ZG-451,0.047619047619047616,0.0,0.0,P51654,Cancer
RPK-739,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-VEGFR2 CD8 cell therapy,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-heparanase mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
AEZS-131,0.047619047619047616,0.0,0.0,P51654,Cancer
PV-1019,0.047619047619047616,0.0,0.0,P51654,Cancer
NSC-73306,0.047619047619047616,0.0,0.0,P51654,Cancer
D-26344,0.047619047619047616,0.0,0.0,P51654,Cancer
Hedgehog pathway antagonists,0.047619047619047616,0.0,0.0,P51654,Cancer
AEZS-126,0.047619047619047616,0.0,0.0,P51654,Cancer
AEZS-127,0.047619047619047616,0.0,0.0,P51654,Cancer
Breceptin,0.047619047619047616,0.0,0.0,P51654,Cancer
ABT-348,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-582664,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
PSP-D-GITRL,0.047619047619047616,0.0,0.0,P51654,Cancer
Ki23819,0.047619047619047616,0.0,0.0,P51654,Cancer
Artemisinin-peptide conjugates,0.047619047619047616,0.0,0.0,P51654,Cancer
Exherin,0.047619047619047616,0.0,0.0,P51654,Cancer
SEL-120,0.047619047619047616,0.0,0.0,P51654,Cancer
Fluorine-18-labelled peptides,0.047619047619047616,0.0,0.0,P51654,Cancer
KM-4056,0.047619047619047616,0.0,0.0,P51654,Cancer
PU3,0.047619047619047616,0.0,0.0,P51654,Cancer
AEZS-115,0.047619047619047616,0.0,0.0,P51654,Cancer
Alloferon,0.047619047619047616,0.0,0.0,P51654,Cancer
Tafluposide,0.047619047619047616,0.0,0.0,P51654,Cancer
MX-76629,0.047619047619047616,0.0,0.0,P51654,Cancer
SIM-010603,0.047619047619047616,0.0,0.0,P51654,Cancer
NKP-2235,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY-94-9392,0.047619047619047616,0.0,0.0,P51654,Cancer
JP-8019,0.047619047619047616,0.0,0.0,P51654,Cancer
OC104-26,0.047619047619047616,0.0,0.0,P51654,Cancer
Silvestrol,0.047619047619047616,0.0,0.0,P51654,Cancer
ACK-1 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
Ki-23057,0.047619047619047616,0.0,0.0,P51654,Cancer
Dactinomycin,0.047619047619047616,0.0,0.0,P51654,Cancer
EPICOAT cancer vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
9cUAB-30,0.047619047619047616,0.0,0.0,P51654,Cancer
Mi-TUMEX,0.047619047619047616,0.0,0.0,P51654,Cancer
Combidex,0.047619047619047616,0.0,0.0,P51654,Cancer
NKTT-320,0.047619047619047616,0.0,0.0,P51654,Cancer
DR-5/DR-4 cross reactive mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
CEN-209,0.047619047619047616,0.0,0.0,P51654,Cancer
Sebriplatin,0.047619047619047616,0.0,0.0,P51654,Cancer
In-111-DAC imaging agent,0.047619047619047616,0.0,0.0,P51654,Cancer
Zemab,0.047619047619047616,0.0,0.0,P51654,Cancer
BI-853520,0.047619047619047616,0.0,0.0,P51654,Cancer
ISIS 16507,0.047619047619047616,0.0,0.0,P51654,Cancer
Theradigm-Melanoma,0.047619047619047616,0.0,0.0,P51654,Cancer
PJ-3505,0.047619047619047616,0.0,0.0,P51654,Cancer
GM-CSF-expressing oncolytic adenovirus,0.047619047619047616,0.0,0.0,P51654,Cancer
UMN-01,0.047619047619047616,0.0,0.0,P51654,Cancer
POP-1,0.047619047619047616,0.0,0.0,P51654,Cancer
GW-788388,0.047619047619047616,0.0,0.0,P51654,Cancer
AGS-16M8FIAGS-16C3F,0.047619047619047616,0.0,0.0,P51654,Cancer
PG-490-88,0.047619047619047616,0.0,0.0,P51654,Cancer
BB-3644,0.047619047619047616,0.0,0.0,P51654,Cancer
CYC-800,0.047619047619047616,0.0,0.0,P51654,Cancer
Epitinib,0.047619047619047616,0.0,0.0,P51654,Cancer
WL-276,0.047619047619047616,0.0,0.0,P51654,Cancer
GSK525762,0.047619047619047616,0.0,0.0,P51654,Cancer
ZK-thiazolidinone,0.047619047619047616,0.0,0.0,P51654,Cancer
LAF-389,0.047619047619047616,0.0,0.0,P51654,Cancer
18F-BAY-85-8050,0.047619047619047616,0.0,0.0,P51654,Cancer
CT-10,0.047619047619047616,0.0,0.0,P51654,Cancer
Diaziquone,0.047619047619047616,0.0,0.0,P51654,Cancer
GTx-027,0.047619047619047616,0.0,0.0,P51654,Cancer
Eptaplatin,0.047619047619047616,0.0,0.0,P51654,Cancer
CU-906,0.047619047619047616,0.0,0.0,P51654,Cancer
Teloxantrone,0.047619047619047616,0.0,0.0,P51654,Cancer
APS-3010,0.047619047619047616,0.0,0.0,P51654,Cancer
BIIB-024,0.047619047619047616,0.0,0.0,P51654,Cancer
GFC-003,0.047619047619047616,0.0,0.0,P51654,Cancer
HGS-TR2J,0.047619047619047616,0.0,0.0,P51654,Cancer
INCB24360,0.047619047619047616,0.0,0.0,P51654,Cancer
XB-05,0.047619047619047616,0.0,0.0,P51654,Cancer
Rexin-G,0.047619047619047616,0.0,0.0,P51654,Cancer
Chromic phosphate P 32,0.047619047619047616,0.0,0.0,P51654,Cancer
Mutant B-Raf kinase inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
E-003,0.047619047619047616,0.0,0.0,P51654,Cancer
SR-3850,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti FGFR4 mAb program,0.047619047619047616,0.0,0.0,P51654,Cancer
AP26113,0.047619047619047616,0.0,0.0,P51654,Cancer
3C23K,0.047619047619047616,0.0,0.0,P51654,Cancer
LC-9018,0.047619047619047616,0.0,0.0,P51654,Cancer
Fusicoccin derivatives,0.047619047619047616,0.0,0.0,P51654,Cancer
TRX-585,0.047619047619047616,0.0,0.0,P51654,Cancer
BE-14106,0.047619047619047616,0.0,0.0,P51654,Cancer
D-1MT,0.047619047619047616,0.0,0.0,P51654,Cancer
Chk1-A,0.047619047619047616,0.0,0.0,P51654,Cancer
LY294002,0.047619047619047616,0.0,0.0,P51654,Cancer
MTOR inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
LIV-1205,0.047619047619047616,0.0,0.0,P51654,Cancer
SNX-5422,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-06647263,0.047619047619047616,0.0,0.0,P51654,Cancer
IKI-1,0.047619047619047616,0.0,0.0,P51654,Cancer
Angeloxin,0.047619047619047616,0.0,0.0,P51654,Cancer
MX-7091,0.047619047619047616,0.0,0.0,P51654,Cancer
MP-RM-1,0.047619047619047616,0.0,0.0,P51654,Cancer
Interferon-alpha dimers,0.047619047619047616,0.0,0.0,P51654,Cancer
TLN-4601,0.047619047619047616,0.0,0.0,P51654,Cancer
EZN-3889,0.047619047619047616,0.0,0.0,P51654,Cancer
F-80002-RR,0.047619047619047616,0.0,0.0,P51654,Cancer
NOX-S91,0.047619047619047616,0.0,0.0,P51654,Cancer
KIN-4064,0.047619047619047616,0.0,0.0,P51654,Cancer
SNX-9,0.047619047619047616,0.0,0.0,P51654,Cancer
TG-3003,0.047619047619047616,0.0,0.0,P51654,Cancer
PB-357,0.047619047619047616,0.0,0.0,P51654,Cancer
VX-689,0.047619047619047616,0.0,0.0,P51654,Cancer
Salinosporamide B,0.047619047619047616,0.0,0.0,P51654,Cancer
Mifamurtide,0.047619047619047616,0.0,0.0,P51654,Cancer
PTX-008,0.047619047619047616,0.0,0.0,P51654,Cancer
Pyriplatin,0.047619047619047616,0.0,0.0,P51654,Cancer
SSR-97225,0.047619047619047616,0.0,0.0,P51654,Cancer
BRX-1002,0.047619047619047616,0.0,0.0,P51654,Cancer
KPC-34,0.047619047619047616,0.0,0.0,P51654,Cancer
ADC-1012,0.047619047619047616,0.0,0.0,P51654,Cancer
CTA-002,0.047619047619047616,0.0,0.0,P51654,Cancer
CTA-001,0.047619047619047616,0.0,0.0,P51654,Cancer
PTL-68001,0.047619047619047616,0.0,0.0,P51654,Cancer
ADC-1013,0.047619047619047616,0.0,0.0,P51654,Cancer
AD5-10,0.047619047619047616,0.0,0.0,P51654,Cancer
DC Bead,0.0,0.0,0.0,P51654,Transcatheter arterial embolization of hepatocellular carcinoma
SN-38,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-03446962,0.047619047619047616,0.0,0.0,P51654,Cancer
Dendritic cell PEG fusion cancer vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
Long-acting IFN-alpha,0.047619047619047616,0.0,0.0,P51654,Cancer
AGX-51,0.047619047619047616,0.0,0.0,P51654,Cancer
F-1013,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY1143572,0.047619047619047616,0.0,0.0,P51654,Cancer
DWP-418,0.047619047619047616,0.0,0.0,P51654,Cancer
L-739749,0.047619047619047616,0.0,0.0,P51654,Cancer
SCH-900776,0.047619047619047616,0.0,0.0,P51654,Cancer
CRT-0004592,0.047619047619047616,0.0,0.0,P51654,Cancer
ALS-769,0.047619047619047616,0.0,0.0,P51654,Cancer
PI3K alpha inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
LP-30171,0.047619047619047616,0.0,0.0,P51654,Cancer
ML-436,0.047619047619047616,0.0,0.0,P51654,Cancer
MX-7065,0.047619047619047616,0.0,0.0,P51654,Cancer
KIN-806,0.047619047619047616,0.0,0.0,P51654,Cancer
MT-503,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1300,0.047619047619047616,0.0,0.0,P51654,Cancer
RG-7446,0.0,0.0,0.0,P51654,Bladder cancer
AVL-292,0.047619047619047616,0.0,0.0,P51654,Cancer
CS-1008,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
HS-7,0.047619047619047616,0.0,0.0,P51654,Cancer
VS1-011,0.047619047619047616,0.0,0.0,P51654,Cancer
Herbimycin A,0.047619047619047616,0.0,0.0,P51654,Cancer
AMG 110,0.047619047619047616,0.0,0.0,P51654,Cancer
Transcobalamin (vitamin B12) receptor-targeting mAbTCR23-saporin conjugate,0.047619047619047616,0.0,0.0,P51654,Cancer
PELITREXOL,0.047619047619047616,0.0,0.0,P51654,Cancer
MLN9708,0.047619047619047616,0.0,0.0,P51654,Cancer
Spirogermanium hydrochloride,0.047619047619047616,0.0,0.0,P51654,Cancer
STA-5312,0.047619047619047616,0.0,0.0,P51654,Cancer
Cat-SPIRE,0.047619047619047616,0.0,0.0,P51654,Cancer
ISIS 16518,0.047619047619047616,0.0,0.0,P51654,Cancer
A-928605,0.047619047619047616,0.0,0.0,P51654,Cancer
DWP-438,0.047619047619047616,0.0,0.0,P51654,Cancer
PT-112,0.047619047619047616,0.0,0.0,P51654,Cancer
EP-100,0.047619047619047616,0.0,0.0,P51654,Cancer
Promostem,0.047619047619047616,0.0,0.0,P51654,Cancer
Cytoros,0.047619047619047616,0.0,0.0,P51654,Cancer
B7-2/GM-CSF,0.047619047619047616,0.0,0.0,P51654,Cancer
RO-5212054,0.047619047619047616,0.0,0.0,P51654,Cancer
SIM-0702,0.047619047619047616,0.0,0.0,P51654,Cancer
EP-2167,0.047619047619047616,0.0,0.0,P51654,Cancer
CH-5015765,0.047619047619047616,0.0,0.0,P51654,Cancer
TBI-302,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
MDX-1204,0.047619047619047616,0.0,0.0,P51654,Cancer
MDX-1203,0.047619047619047616,0.0,0.0,P51654,Cancer
Fosfestrol,0.0,0.0,0.0,P51654,Testicular cancer
PH sensitive micelles,0.047619047619047616,0.0,0.0,P51654,Cancer
BND-002,0.047619047619047616,0.0,0.0,P51654,Cancer
MPC-3100,0.047619047619047616,0.0,0.0,P51654,Cancer
Recombinant therapeutic proteins,0.047619047619047616,0.0,0.0,P51654,Cancer
GSK3052230,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-Notch-1 mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
KOS-1815,0.047619047619047616,0.0,0.0,P51654,Cancer
Cardiotoxin,0.047619047619047616,0.0,0.0,P51654,Cancer
SIM-0710,0.047619047619047616,0.0,0.0,P51654,Cancer
Labetuzumab-SN-38,0.047619047619047616,0.0,0.0,P51654,Cancer
3F8,0.047619047619047616,0.0,0.0,P51654,Cancer
AN-1006,0.047619047619047616,0.0,0.0,P51654,Cancer
NVX-207,0.047619047619047616,0.0,0.0,P51654,Cancer
CC-0101,0.047619047619047616,0.0,0.0,P51654,Cancer
ASP3026,0.047619047619047616,0.0,0.0,P51654,Cancer
CLT-010,0.047619047619047616,0.0,0.0,P51654,Cancer
ANT-429,0.047619047619047616,0.0,0.0,P51654,Cancer
Titanocene dichloride,0.047619047619047616,0.0,0.0,P51654,Cancer
BI-1,0.047619047619047616,0.0,0.0,P51654,Cancer
CBL0102,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
CAP-7.1,0.047619047619047616,0.0,0.0,P51654,Cancer
PEG-PLA-TNP-470,0.047619047619047616,0.0,0.0,P51654,Cancer
Mobenakin,0.047619047619047616,0.0,0.0,P51654,Cancer
AGX-1053,0.047619047619047616,0.0,0.0,P51654,Cancer
KOS-1803,0.047619047619047616,0.0,0.0,P51654,Cancer
MRNA-046,0.047619047619047616,0.0,0.0,P51654,Cancer
MTC-220,0.047619047619047616,0.0,0.0,P51654,Cancer
Aposense probe-cytotoxic agent conjugates,0.047619047619047616,0.0,0.0,P51654,Cancer
MUC-1 dendritic cancer vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
SCH-546909,0.047619047619047616,0.0,0.0,P51654,Cancer
Benzimate,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1109,0.047619047619047616,0.0,0.0,P51654,Cancer
DAP-81,0.047619047619047616,0.0,0.0,P51654,Cancer
BLV-0801,0.047619047619047616,0.0,0.0,P51654,Cancer
Squalamine,0.047619047619047616,0.0,0.0,P51654,Cancer
TGF-BR2 mAb,0.047619047619047616,0.0,0.0,P51654,Cancer
DNA vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
AEG35156,0.047619047619047616,0.0,0.0,P51654,Cancer
APC-003,0.047619047619047616,0.0,0.0,P51654,Cancer
SDX-7400,0.047619047619047616,0.0,0.0,P51654,Cancer
Plicamycin,0.047619047619047616,0.0,0.0,P51654,Cancer
APC-004,0.047619047619047616,0.0,0.0,P51654,Cancer
Etanidazole,0.047619047619047616,0.0,0.0,P51654,Cancer
APC-001,0.047619047619047616,0.0,0.0,P51654,Cancer
Chloromethylpyrrolindolines,0.047619047619047616,0.0,0.0,P51654,Cancer
CYC-700 series,0.047619047619047616,0.0,0.0,P51654,Cancer
Human and mouse gp100 DNA plasmid vaccines,0.047619047619047616,0.0,0.0,P51654,Cancer
UPAR-lock,0.047619047619047616,0.0,0.0,P51654,Cancer
MG-1110,0.047619047619047616,0.0,0.0,P51654,Cancer
NSC-134754,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY 80-6946,0.047619047619047616,0.0,0.0,P51654,Cancer
CTP-conjugated WT1 peptide,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-986016,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-986015,0.047619047619047616,0.0,0.0,P51654,Cancer
DM-PIT-1,0.047619047619047616,0.0,0.0,P51654,Cancer
DISBA-01,0.047619047619047616,0.0,0.0,P51654,Cancer
PPMX-2017,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY1125976,0.047619047619047616,0.0,0.0,P51654,Cancer
SC-236,0.047619047619047616,0.0,0.0,P51654,Cancer
AGS-67E,0.047619047619047616,0.0,0.0,P51654,Cancer
TR-4,0.047619047619047616,0.0,0.0,P51654,Cancer
ARO 087,0.047619047619047616,0.0,0.0,P51654,Cancer
LP-261,0.047619047619047616,0.0,0.0,P51654,Cancer
BI-661051,0.047619047619047616,0.0,0.0,P51654,Cancer
BC-822,0.047619047619047616,0.0,0.0,P51654,Cancer
AKT protein kinase inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
MG-1102,0.047619047619047616,0.0,0.0,P51654,Cancer
L-4-OXALYSINE,0.047619047619047616,0.0,0.0,P51654,Cancer
ZD-6003,0.047619047619047616,0.0,0.0,P51654,Cancer
CXCR-2 targeting mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
P53 mdm-2-binding domain peptides,0.047619047619047616,0.0,0.0,P51654,Cancer
BioScavenger,0.047619047619047616,0.0,0.0,P51654,Cancer
HPMA-gemcitabine conjugate,0.047619047619047616,0.0,0.0,P51654,Cancer
RHIgM12B7,0.047619047619047616,0.0,0.0,P51654,Cancer
Smac mimetics,0.047619047619047616,0.0,0.0,P51654,Cancer
Tiazofurin,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1164,0.047619047619047616,0.0,0.0,P51654,Cancer
RhLT28-171,0.047619047619047616,0.0,0.0,P51654,Cancer
TS antisense + raltitrexed,0.0,0.0,0.0,P51654,Cancer immunotherapy
PAN-622,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-Notch-1 receptor mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
IMT-504,0.047619047619047616,0.0,0.0,P51654,Cancer
Zilascorb (2H),0.047619047619047616,0.0,0.0,P51654,Cancer
RVLYSIN,0.047619047619047616,0.0,0.0,P51654,Cancer
Basal lamina-targeting antiangiogenic agent,0.047619047619047616,0.0,0.0,P51654,Cancer
KU-55933,0.047619047619047616,0.0,0.0,P51654,Cancer
KM-3413,0.047619047619047616,0.0,0.0,P51654,Cancer
MGN-1706,0.047619047619047616,0.0,0.0,P51654,Cancer
Fenbunafide,0.047619047619047616,0.0,0.0,P51654,Cancer
Docetaxel water soluble formulation,0.047619047619047616,0.0,0.0,P51654,Cancer
Rotavirus vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
Tyrophostins,0.047619047619047616,0.0,0.0,P51654,Cancer
Tasonermin,0.0,0.0,0.0,P51654,Adjuvant colorectal cancer
FAS-031,0.047619047619047616,0.0,0.0,P51654,Cancer
TH-1011,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-184476,0.047619047619047616,0.0,0.0,P51654,Cancer
CKD602,0.047619047619047616,0.0,0.0,P51654,Cancer
TM-601,0.047619047619047616,0.0,0.0,P51654,Cancer
WX-037,0.047619047619047616,0.0,0.0,P51654,Cancer
D-1927,0.047619047619047616,0.0,0.0,P51654,Cancer
CIGB-166,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1141,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1143,0.047619047619047616,0.0,0.0,P51654,Cancer
CKD-403,0.047619047619047616,0.0,0.0,P51654,Cancer
MT-101,0.047619047619047616,0.0,0.0,P51654,Cancer
CG-1521,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1144,0.047619047619047616,0.0,0.0,P51654,Cancer
PC-24,0.047619047619047616,0.0,0.0,P51654,Cancer
PC-22,0.047619047619047616,0.0,0.0,P51654,Cancer
Transferrin CRM-107,0.047619047619047616,0.0,0.0,P51654,Cancer
BB-16000,0.047619047619047616,0.0,0.0,P51654,Cancer
CRT0066101,0.047619047619047616,0.0,0.0,P51654,Cancer
EZN-3042,0.047619047619047616,0.0,0.0,P51654,Cancer
Cytochrome P450-targeting prodrugs,0.047619047619047616,0.0,0.0,P51654,Cancer
LJJ-10,0.047619047619047616,0.0,0.0,P51654,Cancer
VK-12,0.047619047619047616,0.0,0.0,P51654,Cancer
PHA-793887,0.047619047619047616,0.0,0.0,P51654,Cancer
SB-2343,0.047619047619047616,0.0,0.0,P51654,Cancer
MT-119,0.047619047619047616,0.0,0.0,P51654,Cancer
NX-1207,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
NBRI-16716a,0.047619047619047616,0.0,0.0,P51654,Cancer
PBI-1393,0.047619047619047616,0.0,0.0,P51654,Cancer
HDAC-42,0.047619047619047616,0.0,0.0,P51654,Cancer
Ro-5287373,0.047619047619047616,0.0,0.0,P51654,Cancer
(S)-8-Hydroxy palmitic acid,0.047619047619047616,0.0,0.0,P51654,Cancer
ACT-GRO-777,0.047619047619047616,0.0,0.0,P51654,Cancer
Oblimersen,0.047619047619047616,0.0,0.0,P51654,Cancer
Resminostat,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
PLX-ORI3,0.047619047619047616,0.0,0.0,P51654,Cancer
CVS-3083,0.047619047619047616,0.0,0.0,P51654,Cancer
EU-517,0.047619047619047616,0.0,0.0,P51654,Cancer
DS-7423,0.047619047619047616,0.0,0.0,P51654,Cancer
LY3009120,0.047619047619047616,0.0,0.0,P51654,Cancer
HL-020,0.047619047619047616,0.0,0.0,P51654,Cancer
MG-516,0.047619047619047616,0.0,0.0,P51654,Cancer
HL-022,0.047619047619047616,0.0,0.0,P51654,Cancer
HL-021,0.047619047619047616,0.0,0.0,P51654,Cancer
HL-024,0.047619047619047616,0.0,0.0,P51654,Cancer
OpsoVac,0.047619047619047616,0.0,0.0,P51654,Cancer
CP-4200,0.047619047619047616,0.0,0.0,P51654,Cancer
HL-023,0.047619047619047616,0.0,0.0,P51654,Cancer
EPI-0030,0.047619047619047616,0.0,0.0,P51654,Cancer
Resten-NG,0.047619047619047616,0.0,0.0,P51654,Cancer
LY2606368,0.047619047619047616,0.0,0.0,P51654,Cancer
OP-06,0.047619047619047616,0.0,0.0,P51654,Cancer
MPGES-1 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
Ropidoxuridine,0.047619047619047616,0.0,0.0,P51654,Cancer
OP-02,0.047619047619047616,0.0,0.0,P51654,Cancer
Alpha-fetoprotein cancer vaccine,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
DMPDDF,0.047619047619047616,0.0,0.0,P51654,Cancer
Protein vaccines,0.047619047619047616,0.0,0.0,P51654,Cancer
HuMax-CD38b,0.047619047619047616,0.0,0.0,P51654,Cancer
TGC-9,0.047619047619047616,0.0,0.0,P51654,Cancer
CC-223,0.047619047619047616,0.0,0.0,P51654,Cancer
ALT-804,0.047619047619047616,0.0,0.0,P51654,Cancer
Anetumab ravantansine,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-00212062,0.047619047619047616,0.0,0.0,P51654,Cancer
EPI-2221,0.047619047619047616,0.0,0.0,P51654,Cancer
Artemisinin trioxane dimers,0.047619047619047616,0.0,0.0,P51654,Cancer
MCT-485,0.047619047619047616,0.0,0.0,P51654,Cancer
Inotuzumab ozogamicin,0.047619047619047616,0.0,0.0,P51654,Cancer
Vaccine; gastrointestinal cancers,0.047619047619047616,0.0,0.0,P51654,Cancer
AG-3296,0.047619047619047616,0.0,0.0,P51654,Cancer
ALT-802,0.047619047619047616,0.0,0.0,P51654,Cancer
ALT-803,0.047619047619047616,0.0,0.0,P51654,Cancer
Fsn-0306,0.047619047619047616,0.0,0.0,P51654,Cancer
GI-6207,0.047619047619047616,0.0,0.0,P51654,Cancer
TALTOBULIN,0.047619047619047616,0.0,0.0,P51654,Cancer
LY3023414,0.047619047619047616,0.0,0.0,P51654,Cancer
NDC-1187,0.047619047619047616,0.0,0.0,P51654,Cancer
RDEA-436,0.047619047619047616,0.0,0.0,P51654,Cancer
EQ-917,0.047619047619047616,0.0,0.0,P51654,Cancer
AP-15012,0.047619047619047616,0.0,0.0,P51654,Cancer
Abexinostat,0.047619047619047616,0.0,0.0,P51654,Cancer
PNT-400,0.047619047619047616,0.0,0.0,P51654,Cancer
PAZELLIPTINE TRIHYDROCHLORIDE,0.047619047619047616,0.0,0.0,P51654,Cancer
MKC-1313,0.047619047619047616,0.0,0.0,P51654,Cancer
MOv18IgE,0.047619047619047616,0.0,0.0,P51654,Cancer
Hoe-33342,0.047619047619047616,0.0,0.0,P51654,Cancer
F61F12,0.047619047619047616,0.0,0.0,P51654,Cancer
C-Met kinase inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
Protease activated prodrug,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1182,0.047619047619047616,0.0,0.0,P51654,Cancer
CYC-103,0.047619047619047616,0.0,0.0,P51654,Cancer
Peretinoin,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
SL-11093,0.047619047619047616,0.0,0.0,P51654,Cancer
XL999,0.0,0.0,0.0,P51654,Advanced malignancies
S-024,0.047619047619047616,0.0,0.0,P51654,Cancer
CT-200,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-CD326 humanized mAb,0.047619047619047616,0.0,0.0,P51654,Cancer
NU-1001-41,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1179,0.047619047619047616,0.0,0.0,P51654,Cancer
LY-GSK-3i,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-06263507,0.047619047619047616,0.0,0.0,P51654,Cancer
MCT-465,0.047619047619047616,0.0,0.0,P51654,Cancer
Dendrogenin A,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY-86-7548,0.047619047619047616,0.0,0.0,P51654,Cancer
Anticancer therapy; Aurigene Discovery Technologies,0.047619047619047616,0.0,0.0,P51654,Cancer
Prolarix,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-EGFR humanized mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
Dibenzoylmethane,0.047619047619047616,0.0,0.0,P51654,Cancer
GSK2816126,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1177,0.047619047619047616,0.0,0.0,P51654,Cancer
XL-541,0.047619047619047616,0.0,0.0,P51654,Cancer
LEE011,0.047619047619047616,0.0,0.0,P51654,Cancer
IDN-6384,0.047619047619047616,0.0,0.0,P51654,Cancer
HO-4073,0.047619047619047616,0.0,0.0,P51654,Cancer
131i-chtnt,0.047619047619047616,0.0,0.0,P51654,Cancer
Chondrogel,0.047619047619047616,0.0,0.0,P51654,Cancer
TETRAPLATIN TETRANITRATE,0.047619047619047616,0.0,0.0,P51654,Cancer
R-roscovitine,0.047619047619047616,0.0,0.0,P51654,Cancer
DAVLB-HYDRAZIDE,0.047619047619047616,0.0,0.0,P51654,Cancer
P-7170,0.047619047619047616,0.0,0.0,P51654,Cancer
PMA-BB10,0.047619047619047616,0.0,0.0,P51654,Cancer
JBP-1,0.047619047619047616,0.0,0.0,P51654,Cancer
Autologous fat-derived stem cell therapy,0.047619047619047616,0.0,0.0,P51654,Cancer
Liposomal encapsulated paclitaxel (LEP),0.047619047619047616,0.0,0.0,P51654,Cancer
FG-020318,0.047619047619047616,0.0,0.0,P51654,Cancer
TH-337,0.047619047619047616,0.0,0.0,P51654,Cancer
Tirapazamine derivatives,0.047619047619047616,0.0,0.0,P51654,Cancer
BO-110,0.047619047619047616,0.0,0.0,P51654,Cancer
OG-9,0.047619047619047616,0.0,0.0,P51654,Cancer
PX-478,0.047619047619047616,0.0,0.0,P51654,Cancer
CZ-775,0.047619047619047616,0.0,0.0,P51654,Cancer
SS1(dsFv)-PE38,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-03084014,0.047619047619047616,0.0,0.0,P51654,Cancer
AMG 820,0.047619047619047616,0.0,0.0,P51654,Cancer
HPMA-docetaxel conjugate,0.047619047619047616,0.0,0.0,P51654,Cancer
Doxifluridine,0.047619047619047616,0.0,0.0,P51654,Cancer
JP-1201,0.047619047619047616,0.0,0.0,P51654,Cancer
G6976,0.047619047619047616,0.0,0.0,P51654,Cancer
SAR-405838,0.047619047619047616,0.0,0.0,P51654,Cancer
TNF-PEG-20,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY1163877,0.047619047619047616,0.0,0.0,P51654,Cancer
MST-400,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-3758309,0.047619047619047616,0.0,0.0,P51654,Cancer
VE-04051645,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY 1082439,0.047619047619047616,0.0,0.0,P51654,Cancer
PI-083,0.047619047619047616,0.0,0.0,P51654,Cancer
CAI orotate,0.0,0.0,0.0,P51654,Age-related macular degeneration
BAY1129980,0.047619047619047616,0.0,0.0,P51654,Cancer
KST-301,0.047619047619047616,0.0,0.0,P51654,Cancer
Rad51,0.047619047619047616,0.0,0.0,P51654,Cancer
D-699126,0.047619047619047616,0.0,0.0,P51654,Cancer
CJX-1,0.047619047619047616,0.0,0.0,P51654,Cancer
Curmucin,0.047619047619047616,0.0,0.0,P51654,Cancer
SCH-1595241,0.047619047619047616,0.0,0.0,P51654,Cancer
TAK-593,0.047619047619047616,0.0,0.0,P51654,Cancer
PEG arginine deiminase,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
XN-0502,0.047619047619047616,0.0,0.0,P51654,Cancer
VSSP,0.047619047619047616,0.0,0.0,P51654,Cancer
Epothilone B,0.047619047619047616,0.0,0.0,P51654,Cancer
Oshadi D,0.047619047619047616,0.0,0.0,P51654,Cancer
HM-5016504,0.047619047619047616,0.0,0.0,P51654,Cancer
UltraGITRL,0.047619047619047616,0.0,0.0,P51654,Cancer
Histone deacetylase inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
AFX-9901,0.047619047619047616,0.0,0.0,P51654,Cancer
Ad-p53,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-06463922,0.047619047619047616,0.0,0.0,P51654,Cancer
Enocitabine,0.047619047619047616,0.0,0.0,P51654,Cancer
TG-6002,0.047619047619047616,0.0,0.0,P51654,Cancer
KML-001,0.047619047619047616,0.0,0.0,P51654,Cancer
Autologous dendritic cell therapy,0.047619047619047616,0.0,0.0,P51654,Cancer
Oshadi R,0.047619047619047616,0.0,0.0,P51654,Cancer
ZP-10395,0.047619047619047616,0.0,0.0,P51654,Cancer
Hypoxic response inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
Galectin-3C,0.047619047619047616,0.0,0.0,P51654,Cancer
G1T28-1,0.047619047619047616,0.0,0.0,P51654,Cancer
PAT-CSL1,0.047619047619047616,0.0,0.0,P51654,Cancer
D-21805,0.047619047619047616,0.0,0.0,P51654,Cancer
BN-82002,0.047619047619047616,0.0,0.0,P51654,Cancer
KST-401,0.047619047619047616,0.0,0.0,P51654,Cancer
Vinblastine,0.047619047619047616,0.0,0.0,P51654,Cancer
YP-004,0.047619047619047616,0.0,0.0,P51654,Cancer
Isovanillin,0.047619047619047616,0.0,0.0,P51654,Cancer
DM-204,0.047619047619047616,0.0,0.0,P51654,Cancer
AG-122005,0.047619047619047616,0.0,0.0,P51654,Cancer
RX-0201N,0.047619047619047616,0.0,0.0,P51654,Cancer
T1-IR,0.047619047619047616,0.0,0.0,P51654,Cancer
CP-471358,0.047619047619047616,0.0,0.0,P51654,Cancer
CGEN-671,0.047619047619047616,0.0,0.0,P51654,Cancer
SWA11-ZZ-PE38,0.047619047619047616,0.0,0.0,P51654,Cancer
FolateImmune,0.047619047619047616,0.0,0.0,P51654,Cancer
Trimidox,0.047619047619047616,0.0,0.0,P51654,Cancer
CX-1001,0.047619047619047616,0.0,0.0,P51654,Cancer
INP-04,0.047619047619047616,0.0,0.0,P51654,Cancer
NMS-E628,0.047619047619047616,0.0,0.0,P51654,Cancer
BPR-DC-2,0.047619047619047616,0.0,0.0,P51654,Cancer
TrasGEX,0.047619047619047616,0.0,0.0,P51654,Cancer
NVP-LDE276,0.047619047619047616,0.0,0.0,P51654,Cancer
FRAX-120,0.047619047619047616,0.0,0.0,P51654,Cancer
IDR-803,0.047619047619047616,0.0,0.0,P51654,Cancer
Anticancer glycosaminoglycans,0.047619047619047616,0.0,0.0,P51654,Cancer
CLOTURIN,0.047619047619047616,0.0,0.0,P51654,Cancer
PHY-906,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
123-Iodine-labeled MFE-23,0.047619047619047616,0.0,0.0,P51654,Cancer
Protein-silencing drugs,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-GP88 mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
PMA-104R,0.047619047619047616,0.0,0.0,P51654,Cancer
Lomeguatrib,0.047619047619047616,0.0,0.0,P51654,Cancer
Kinetochore-microtubule binding inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
LOR 253,0.047619047619047616,0.0,0.0,P51654,Cancer
VG-106,0.047619047619047616,0.0,0.0,P51654,Cancer
CYCLOPLATAM,0.047619047619047616,0.0,0.0,P51654,Cancer
VG-102,0.047619047619047616,0.0,0.0,P51654,Cancer
MP-PN-2,0.047619047619047616,0.0,0.0,P51654,Cancer
MP-PN-1,0.047619047619047616,0.0,0.0,P51654,Cancer
ED-110,0.047619047619047616,0.0,0.0,P51654,Cancer
EZN-3920,0.047619047619047616,0.0,0.0,P51654,Cancer
SAR-020106,0.047619047619047616,0.0,0.0,P51654,Cancer
IPH-3201,0.047619047619047616,0.0,0.0,P51654,Cancer
Benzyldihydroxyoctenone,0.047619047619047616,0.0,0.0,P51654,Cancer
NMS-P626,0.047619047619047616,0.0,0.0,P51654,Cancer
Adva-27a,0.047619047619047616,0.0,0.0,P51654,Cancer
EphB4 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
PNU-248686A,0.047619047619047616,0.0,0.0,P51654,Cancer
ABI-2088,0.047619047619047616,0.0,0.0,P51654,Cancer
ARRY-300,0.047619047619047616,0.0,0.0,P51654,Cancer
HER1-VSSP vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
AMT-2003,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
MIVOBULIN ISETHIONATE,0.047619047619047616,0.0,0.0,P51654,Cancer
CD19xCD3 DART,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-tubulin agents,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-04691502,0.047619047619047616,0.0,0.0,P51654,Cancer
Mitoflaxone,0.047619047619047616,0.0,0.0,P51654,Cancer
AZ-628,0.047619047619047616,0.0,0.0,P51654,Cancer
AZD8055,0.047619047619047616,0.0,0.0,P51654,Cancer
LY309887,0.047619047619047616,0.0,0.0,P51654,Cancer
PV-921,0.047619047619047616,0.0,0.0,P51654,Cancer
AP-11014,0.047619047619047616,0.0,0.0,P51654,Cancer
SG-2274,0.047619047619047616,0.0,0.0,P51654,Cancer
GTx-186,0.047619047619047616,0.0,0.0,P51654,Cancer
IODOSTEARIC ACID,0.047619047619047616,0.0,0.0,P51654,Cancer
VM-206,0.047619047619047616,0.0,0.0,P51654,Cancer
Fc-IFN alpha 2b,0.047619047619047616,0.0,0.0,P51654,Cancer
CLDC,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
NSC-88915,0.047619047619047616,0.0,0.0,P51654,Cancer
3-CLA,0.047619047619047616,0.0,0.0,P51654,Cancer
TP-801,0.047619047619047616,0.0,0.0,P51654,Cancer
E-7107,0.047619047619047616,0.0,0.0,P51654,Cancer
MNX-100,0.047619047619047616,0.0,0.0,P51654,Cancer
LY333531,0.047619047619047616,0.0,0.0,P51654,Cancer
BST-204,0.047619047619047616,0.0,0.0,P51654,Cancer
DPK-DTSM-02,0.047619047619047616,0.0,0.0,P51654,Cancer
CS-00028,0.047619047619047616,0.0,0.0,P51654,Cancer
Cipatinib,0.047619047619047616,0.0,0.0,P51654,Cancer
LY2090314,0.047619047619047616,0.0,0.0,P51654,Cancer
COP1-LNP,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
R-253,0.047619047619047616,0.0,0.0,P51654,Cancer
SV-BR-1-GM,0.047619047619047616,0.0,0.0,P51654,Cancer
Cancer therapy; ProMediTech Inc,0.047619047619047616,0.0,0.0,P51654,Cancer
ELACRIDAR,0.047619047619047616,0.0,0.0,P51654,Cancer
Viraplex,0.047619047619047616,0.0,0.0,P51654,Cancer
ATOFLUDING,0.047619047619047616,0.0,0.0,P51654,Cancer
YP-009,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY 2010112,0.047619047619047616,0.0,0.0,P51654,Cancer
NCTX,0.047619047619047616,0.0,0.0,P51654,Cancer
CKD-10101,0.047619047619047616,0.0,0.0,P51654,Cancer
CX-4945,0.047619047619047616,0.0,0.0,P51654,Cancer
CetuGEX,0.047619047619047616,0.0,0.0,P51654,Cancer
H-102,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
H-101,0.047619047619047616,0.0,0.0,P51654,Cancer
TRIN-2755,0.047619047619047616,0.0,0.0,P51654,Cancer
PP-405,0.047619047619047616,0.0,0.0,P51654,Cancer
Debio-0617,0.047619047619047616,0.0,0.0,P51654,Cancer
KC-7F2,0.047619047619047616,0.0,0.0,P51654,Cancer
ARRY-770,0.047619047619047616,0.0,0.0,P51654,Cancer
KRX-0403,0.047619047619047616,0.0,0.0,P51654,Cancer
JBD-401,0.047619047619047616,0.0,0.0,P51654,Cancer
CBS-9106,0.047619047619047616,0.0,0.0,P51654,Cancer
I-387,0.047619047619047616,0.0,0.0,P51654,Cancer
PMA-109R,0.047619047619047616,0.0,0.0,P51654,Cancer
Ceruletide,0.047619047619047616,0.0,0.0,P51654,Cancer
RK-28,0.047619047619047616,0.0,0.0,P51654,Cancer
oxazine 89,0.047619047619047616,0.0,0.0,P51654,Cancer
BCH-2051,0.047619047619047616,0.0,0.0,P51654,Cancer
ISIS 15770,0.047619047619047616,0.0,0.0,P51654,Cancer
Metallo-SAHA,0.047619047619047616,0.0,0.0,P51654,Cancer
NVX-272,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY 86-9766,0.047619047619047616,0.0,0.0,P51654,Cancer
UCB-1350883,0.047619047619047616,0.0,0.0,P51654,Cancer
TRC-102 iv,0.047619047619047616,0.0,0.0,P51654,Cancer
TZ-93,0.047619047619047616,0.0,0.0,P51654,Cancer
CX-5461,0.047619047619047616,0.0,0.0,P51654,Cancer
MM-131,0.047619047619047616,0.0,0.0,P51654,Cancer
ABT-413,0.047619047619047616,0.0,0.0,P51654,Cancer
RON8 mAb,0.047619047619047616,0.0,0.0,P51654,Cancer
KT-105,0.047619047619047616,0.0,0.0,P51654,Cancer
PHA-690509,0.047619047619047616,0.0,0.0,P51654,Cancer
TeloB-Vax,0.047619047619047616,0.0,0.0,P51654,Cancer
WEHI-0103122,0.047619047619047616,0.0,0.0,P51654,Cancer
8H9,0.047619047619047616,0.0,0.0,P51654,Cancer
AGS-6MF,0.047619047619047616,0.0,0.0,P51654,Cancer
NRC-2694,0.047619047619047616,0.0,0.0,P51654,Cancer
Angiozyme,0.047619047619047616,0.0,0.0,P51654,Cancer
BCT-100,0.047619047619047616,0.0,0.0,P51654,Cancer
Lexatumumab,0.047619047619047616,0.0,0.0,P51654,Cancer
Elmustine,0.047619047619047616,0.0,0.0,P51654,Cancer
Romurtide,0.047619047619047616,0.0,0.0,P51654,Cancer
CXCR7 pepducins,0.047619047619047616,0.0,0.0,P51654,Cancer
SIL-43,0.047619047619047616,0.0,0.0,P51654,Cancer
XR-9051,0.047619047619047616,0.0,0.0,P51654,Cancer
227Th-rituximab (cancer); Algeta,0.047619047619047616,0.0,0.0,P51654,Cancer
PAT-SM4,0.047619047619047616,0.0,0.0,P51654,Cancer
PAT-SM5,0.047619047619047616,0.0,0.0,P51654,Cancer
SiRNA agent; cancer; respiratory/metabolic/liver diseases,0.0,0.0,0.0,P51654,Diabetic nephropathies
OCID-4681,0.047619047619047616,0.0,0.0,P51654,Cancer
Anticancer stem cell therapeutics,0.047619047619047616,0.0,0.0,P51654,Cancer
TAN-1496,0.047619047619047616,0.0,0.0,P51654,Cancer
IMD-015213,0.047619047619047616,0.0,0.0,P51654,Cancer
AK-1,0.047619047619047616,0.0,0.0,P51654,Cancer
GTx-134,0.047619047619047616,0.0,0.0,P51654,Cancer
GS-9219,0.047619047619047616,0.0,0.0,P51654,Cancer
MM-151,0.047619047619047616,0.0,0.0,P51654,Cancer
IGF-1R inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
PAT-SM3,0.047619047619047616,0.0,0.0,P51654,Cancer
BIBH 1,0.047619047619047616,0.0,0.0,P51654,Cancer
Anticancer etherlipid prodrugs,0.047619047619047616,0.0,0.0,P51654,Cancer
CS-0230,0.047619047619047616,0.0,0.0,P51654,Cancer
ATI-1150,0.047619047619047616,0.0,0.0,P51654,Cancer
CMS-024-02,0.047619047619047616,0.0,0.0,P51654,Cancer
ON-01135,0.047619047619047616,0.0,0.0,P51654,Cancer
CP-870893,0.047619047619047616,0.0,0.0,P51654,Cancer
CLR-1404,0.047619047619047616,0.0,0.0,P51654,Cancer
CLR-1401,0.047619047619047616,0.0,0.0,P51654,Cancer
D-81050,0.047619047619047616,0.0,0.0,P51654,Cancer
CIGB-598a,0.047619047619047616,0.0,0.0,P51654,Cancer
MM-141,0.047619047619047616,0.0,0.0,P51654,Cancer
AF-11,0.047619047619047616,0.0,0.0,P51654,Cancer
EphB4-131,0.047619047619047616,0.0,0.0,P51654,Cancer
MMPT,0.047619047619047616,0.0,0.0,P51654,Cancer
NM-3,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1209,0.047619047619047616,0.0,0.0,P51654,Cancer
IB-06F259,0.047619047619047616,0.0,0.0,P51654,Cancer
ARRY-380,0.047619047619047616,0.0,0.0,P51654,Cancer
R763,0.047619047619047616,0.0,0.0,P51654,Cancer
CDX-301,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1202,0.047619047619047616,0.0,0.0,P51654,Cancer
ARRY-382,0.047619047619047616,0.0,0.0,P51654,Cancer
BA-016,0.047619047619047616,0.0,0.0,P51654,Cancer
Mapatumumab,0.0,0.0,0.0,P51654,Advanced hepatocellular carcinoma
X-387,0.047619047619047616,0.0,0.0,P51654,Cancer
APX-009,0.047619047619047616,0.0,0.0,P51654,Cancer
IPS-01003,0.047619047619047616,0.0,0.0,P51654,Cancer
HM-90822,0.047619047619047616,0.0,0.0,P51654,Cancer
Avicin D,0.047619047619047616,0.0,0.0,P51654,Cancer
Ubiquitin-specific protease-8 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
RGel-Adnectin,0.047619047619047616,0.0,0.0,P51654,Cancer
EP-200,0.047619047619047616,0.0,0.0,P51654,Cancer
Iobitridol,0.047619047619047616,0.0,0.0,P51654,Cancer
CXD-101,0.047619047619047616,0.0,0.0,P51654,Cancer
99mTc-EC-DG,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-PECAM-1 mAb,0.047619047619047616,0.0,0.0,P51654,Cancer
Fotemustine,0.047619047619047616,0.0,0.0,P51654,Cancer
GDC-0349,0.047619047619047616,0.0,0.0,P51654,Cancer
TL-32711,0.047619047619047616,0.0,0.0,P51654,Cancer
Teceleukin,0.047619047619047616,0.0,0.0,P51654,Cancer
XR-1500,0.047619047619047616,0.0,0.0,P51654,Cancer
Histidase-PEG-20,0.047619047619047616,0.0,0.0,P51654,Cancer
MK-5108,0.047619047619047616,0.0,0.0,P51654,Cancer
Tapet,0.047619047619047616,0.0,0.0,P51654,Cancer
RHuEPO,0.047619047619047616,0.0,0.0,P51654,Cancer
Pegaspargase,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-753493,0.047619047619047616,0.0,0.0,P51654,Cancer
Sulfatinib,0.047619047619047616,0.0,0.0,P51654,Cancer
VER-155008,0.047619047619047616,0.0,0.0,P51654,Cancer
EPI-288,0.047619047619047616,0.0,0.0,P51654,Cancer
Gp75 DNA vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
Phytosel,0.047619047619047616,0.0,0.0,P51654,Cancer
MTD-102,0.047619047619047616,0.0,0.0,P51654,Cancer
CEP-37249,0.047619047619047616,0.0,0.0,P51654,Cancer
SPI-1620,0.047619047619047616,0.0,0.0,P51654,Cancer
LYS-6KAKT1,0.047619047619047616,0.0,0.0,P51654,Cancer
Theliatinib,0.047619047619047616,0.0,0.0,P51654,Cancer
LY2801653,0.047619047619047616,0.0,0.0,P51654,Cancer
M-402,0.047619047619047616,0.0,0.0,P51654,Cancer
KP-27,0.047619047619047616,0.0,0.0,P51654,Cancer
ISC-4,0.047619047619047616,0.0,0.0,P51654,Cancer
S-9788,0.047619047619047616,0.0,0.0,P51654,Cancer
CIGB-552,0.047619047619047616,0.0,0.0,P51654,Cancer
MINT-1526A,0.047619047619047616,0.0,0.0,P51654,Cancer
TRK-710,0.047619047619047616,0.0,0.0,P51654,Cancer
XL147,0.047619047619047616,0.0,0.0,P51654,Cancer
Emdogain,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-185857,0.047619047619047616,0.0,0.0,P51654,Cancer
6-azacytidine; National Academy of Sciences of Ukraine,0.047619047619047616,0.0,0.0,P51654,Cancer
ST-2987,0.047619047619047616,0.0,0.0,P51654,Cancer
AMG 337,0.047619047619047616,0.0,0.0,P51654,Cancer
EC-0531,0.047619047619047616,0.0,0.0,P51654,Cancer
CL-5343,0.047619047619047616,0.0,0.0,P51654,Cancer
BIIB 022,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
PF-3732010,0.047619047619047616,0.0,0.0,P51654,Cancer
Schizophyllan,0.047619047619047616,0.0,0.0,P51654,Cancer
Prednimustine,0.047619047619047616,0.0,0.0,P51654,Cancer
CST-101,0.047619047619047616,0.0,0.0,P51654,Cancer
18F labeled ethanolamine derivatives (cancer imaging); Bayer Schering,0.047619047619047616,0.0,0.0,P51654,Cancer
Proapoptotic Surrobodies,0.047619047619047616,0.0,0.0,P51654,Cancer
LP-205A1,0.047619047619047616,0.0,0.0,P51654,Cancer
CST-104,0.047619047619047616,0.0,0.0,P51654,Cancer
Hsp90 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
HuMax-Wnt,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-906024,0.047619047619047616,0.0,0.0,P51654,Cancer
BAF312,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
CID755673,0.047619047619047616,0.0,0.0,P51654,Cancer
LY2606368 MsOH H2O,0.047619047619047616,0.0,0.0,P51654,Cancer
CXR-1002,0.047619047619047616,0.0,0.0,P51654,Cancer
ML-721,0.047619047619047616,0.0,0.0,P51654,Cancer
TEM-8-Fc,0.047619047619047616,0.0,0.0,P51654,Cancer
SB-101,0.047619047619047616,0.0,0.0,P51654,Cancer
Timcodar dimesilate,0.047619047619047616,0.0,0.0,P51654,Cancer
Oral immunoglobulin,0.047619047619047616,0.0,0.0,P51654,Cancer
Vivia-1615,0.047619047619047616,0.0,0.0,P51654,Cancer
EGFR/IGFR tandem adnectin,0.047619047619047616,0.0,0.0,P51654,Cancer
CKD-712,0.047619047619047616,0.0,0.0,P51654,Cancer
Mithramycin,0.047619047619047616,0.0,0.0,P51654,Cancer
NLCQ-1,0.047619047619047616,0.0,0.0,P51654,Cancer
SARMs,0.047619047619047616,0.0,0.0,P51654,Cancer
ABC294640,0.047619047619047616,0.0,0.0,P51654,Cancer
TGN-208,0.047619047619047616,0.0,0.0,P51654,Cancer
IL-2 mimetic peptides,0.047619047619047616,0.0,0.0,P51654,Cancer
ERK inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
HBX-41108,0.047619047619047616,0.0,0.0,P51654,Cancer
CZ-48,0.047619047619047616,0.0,0.0,P51654,Cancer
IMC-3C5,0.047619047619047616,0.0,0.0,P51654,Cancer
BN-OD-026,0.047619047619047616,0.0,0.0,P51654,Cancer
Aviscumine,0.047619047619047616,0.0,0.0,P51654,Cancer
SMT-A07,0.047619047619047616,0.0,0.0,P51654,Cancer
SR13668,0.047619047619047616,0.0,0.0,P51654,Cancer
S-12363,0.047619047619047616,0.0,0.0,P51654,Cancer
PTL-43401,0.047619047619047616,0.0,0.0,P51654,Cancer
TAS-114,0.047619047619047616,0.0,0.0,P51654,Cancer
Pidilizumab,0.047619047619047616,0.0,0.0,P51654,Cancer
Oncopurge,0.047619047619047616,0.0,0.0,P51654,Cancer
Nadrolone phenylpropionate,0.047619047619047616,0.0,0.0,P51654,Cancer
31.1Chi,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY1161909,0.047619047619047616,0.0,0.0,P51654,Cancer
SR-11237,0.047619047619047616,0.0,0.0,P51654,Cancer
DSLIM,0.047619047619047616,0.0,0.0,P51654,Cancer
Kuzbanian,0.047619047619047616,0.0,0.0,P51654,Cancer
EphA2-targeting BiTE molecules,0.047619047619047616,0.0,0.0,P51654,Cancer
LCL-161,0.047619047619047616,0.0,0.0,P51654,Cancer
Oxibendazole,0.047619047619047616,0.0,0.0,P51654,Cancer
Radioimmunotherapy,0.047619047619047616,0.0,0.0,P51654,Cancer
HS-1183,0.047619047619047616,0.0,0.0,P51654,Cancer
Apogossypol,0.047619047619047616,0.0,0.0,P51654,Cancer
Cancer therapy; Revalesio Corp,0.047619047619047616,0.0,0.0,P51654,Cancer
Mofarotene,0.047619047619047616,0.0,0.0,P51654,Cancer
E-758,0.047619047619047616,0.0,0.0,P51654,Cancer
OctreoScan,0.047619047619047616,0.0,0.0,P51654,Cancer
HuGAL-F2,0.047619047619047616,0.0,0.0,P51654,Cancer
Ostarine,0.047619047619047616,0.0,0.0,P51654,Cancer
EP-2060,0.047619047619047616,0.0,0.0,P51654,Cancer
ADXS-HPV,0.047619047619047616,0.0,0.0,P51654,Cancer
ITE,0.047619047619047616,0.0,0.0,P51654,Cancer
SMTP-0,0.047619047619047616,0.0,0.0,P51654,Cancer
RNAi therapeutics; Alnylam,0.047619047619047616,0.0,0.0,P51654,Cancer
IPI-194,0.047619047619047616,0.0,0.0,P51654,Cancer
CEMADOTIN HYDROCHLORIDE,0.047619047619047616,0.0,0.0,P51654,Cancer
FD-891,0.047619047619047616,0.0,0.0,P51654,Cancer
GDC-0853,0.047619047619047616,0.0,0.0,P51654,Cancer
ICT-111,0.047619047619047616,0.0,0.0,P51654,Cancer
IMM-101,0.047619047619047616,0.0,0.0,P51654,Cancer
PERFOSFAMIDE,0.047619047619047616,0.0,0.0,P51654,Cancer
PX-12,0.047619047619047616,0.0,0.0,P51654,Cancer
NOPPI,0.047619047619047616,0.0,0.0,P51654,Cancer
Pyroxamide,0.047619047619047616,0.0,0.0,P51654,Cancer
Trimelamol,0.047619047619047616,0.0,0.0,P51654,Cancer
Taxotere-Mab,0.047619047619047616,0.0,0.0,P51654,Cancer
FE-999040,0.047619047619047616,0.0,0.0,P51654,Cancer
MKC-1106-PP,0.047619047619047616,0.0,0.0,P51654,Cancer
HM-61713B,0.047619047619047616,0.0,0.0,P51654,Cancer
HPPH photodynamic therapy,0.047619047619047616,0.0,0.0,P51654,Cancer
ImmuCyst,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
CX-5011,0.047619047619047616,0.0,0.0,P51654,Cancer
AlloStim,0.047619047619047616,0.0,0.0,P51654,Cancer
Targeted vascular disrupting agent,0.047619047619047616,0.0,0.0,P51654,Cancer
T-506,0.047619047619047616,0.0,0.0,P51654,Cancer
AMG 780,0.047619047619047616,0.0,0.0,P51654,Cancer
SID-530,0.047619047619047616,0.0,0.0,P51654,Cancer
Bisplatinum complexes,0.047619047619047616,0.0,0.0,P51654,Cancer
MP40X,0.047619047619047616,0.0,0.0,P51654,Cancer
MIRNA-Rx07,0.047619047619047616,0.0,0.0,P51654,Cancer
BPI-704001,0.047619047619047616,0.0,0.0,P51654,Cancer
XN-05,0.047619047619047616,0.0,0.0,P51654,Cancer
131I-CLR-1404,0.047619047619047616,0.0,0.0,P51654,Cancer
EZN-4482,0.047619047619047616,0.0,0.0,P51654,Cancer
AbGn-7,0.047619047619047616,0.0,0.0,P51654,Cancer
209-342,0.047619047619047616,0.0,0.0,P51654,Cancer
Pyrroles,0.047619047619047616,0.0,0.0,P51654,Cancer
AC-03-636,0.047619047619047616,0.0,0.0,P51654,Cancer
HDAC inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
Thymidine kinase-expressing adenovirus and ganciclovir suicide gene therapy,0.047619047619047616,0.0,0.0,P51654,Cancer
Famitinib,0.047619047619047616,0.0,0.0,P51654,Cancer
ING-1,0.047619047619047616,0.0,0.0,P51654,Cancer
QG-AGC1,0.047619047619047616,0.0,0.0,P51654,Cancer
Fludeoxyglucose F 18,0.047619047619047616,0.0,0.0,P51654,Cancer
MK-2206,0.047619047619047616,0.0,0.0,P51654,Cancer
INK4a,0.047619047619047616,0.0,0.0,P51654,Cancer
CHML,0.047619047619047616,0.0,0.0,P51654,Cancer
BPKDi,0.047619047619047616,0.0,0.0,P51654,Cancer
Lucanthone,0.047619047619047616,0.0,0.0,P51654,Cancer
BmAb-100,0.047619047619047616,0.0,0.0,P51654,Cancer
OVI-117,0.047619047619047616,0.0,0.0,P51654,Cancer
14F7 humanized mAb; The Center of Molecular Immunology,0.047619047619047616,0.0,0.0,P51654,Cancer
ICT-121,0.047619047619047616,0.0,0.0,P51654,Cancer
Tefinostat,0.047619047619047616,0.0,0.0,P51654,Cancer
OPB-51602,0.047619047619047616,0.0,0.0,P51654,Cancer
GS-438,0.047619047619047616,0.0,0.0,P51654,Cancer
CPC-410,0.047619047619047616,0.0,0.0,P51654,Cancer
Debio-1142,0.047619047619047616,0.0,0.0,P51654,Cancer
CGEN-25008,0.047619047619047616,0.0,0.0,P51654,Cancer
MAb 37.1,0.047619047619047616,0.0,0.0,P51654,Cancer
Oral paclitaxel,0.047619047619047616,0.0,0.0,P51654,Cancer
BQS-481,0.047619047619047616,0.0,0.0,P51654,Cancer
Adva-33c,0.047619047619047616,0.0,0.0,P51654,Cancer
IPC-003,0.047619047619047616,0.0,0.0,P51654,Cancer
Curcumin I,0.047619047619047616,0.0,0.0,P51654,Cancer
RO-4920506,0.047619047619047616,0.0,0.0,P51654,Cancer
NDC-KM,0.047619047619047616,0.0,0.0,P51654,Cancer
SB-1578,0.047619047619047616,0.0,0.0,P51654,Cancer
Mab17-1a,0.047619047619047616,0.0,0.0,P51654,Cancer
GUT-70,0.047619047619047616,0.0,0.0,P51654,Cancer
LGK974,0.047619047619047616,0.0,0.0,P51654,Cancer
SEL-24,0.047619047619047616,0.0,0.0,P51654,Cancer
Terpenoid schweinfurthins,0.047619047619047616,0.0,0.0,P51654,Cancer
IDN-5390,0.047619047619047616,0.0,0.0,P51654,Cancer
Milataxel,0.047619047619047616,0.0,0.0,P51654,Cancer
ATN-658,0.047619047619047616,0.0,0.0,P51654,Cancer
NM-006-MENK,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1072,0.047619047619047616,0.0,0.0,P51654,Cancer
Fruquintinib,0.047619047619047616,0.0,0.0,P51654,Cancer
CC-115,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1077,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1076,0.047619047619047616,0.0,0.0,P51654,Cancer
PRX-321,0.047619047619047616,0.0,0.0,P51654,Cancer
AXL-1717,0.047619047619047616,0.0,0.0,P51654,Cancer
PG-11144,0.047619047619047616,0.0,0.0,P51654,Cancer
HSP-990,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1078,0.047619047619047616,0.0,0.0,P51654,Cancer
CZ-ON002,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1071,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1070,0.047619047619047616,0.0,0.0,P51654,Cancer
Soluble ErbB3 theragnostics,0.047619047619047616,0.0,0.0,P51654,Cancer
RP-525,0.047619047619047616,0.0,0.0,P51654,Cancer
VX-944,0.047619047619047616,0.0,0.0,P51654,Cancer
F-12458,0.047619047619047616,0.0,0.0,P51654,Cancer
Endostatin,0.047619047619047616,0.0,0.0,P51654,Cancer
SKI-2034R,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-DLL-4 mAb,0.047619047619047616,0.0,0.0,P51654,Cancer
CVX-241,0.047619047619047616,0.0,0.0,P51654,Cancer
BI-836845,0.047619047619047616,0.0,0.0,P51654,Cancer
AZD2014,0.047619047619047616,0.0,0.0,P51654,Cancer
BN-80245,0.047619047619047616,0.0,0.0,P51654,Cancer
BST-1005,0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1068,0.047619047619047616,0.0,0.0,P51654,Cancer
Hemomex I,0.047619047619047616,0.0,0.0,P51654,Cancer
EM-101,0.047619047619047616,0.0,0.0,P51654,Cancer
Selective Rac1/1b GTPase nucleotide binding inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
Anticancer/antidiabetic protein,0.047619047619047616,0.0,0.0,P51654,Cancer
CGP-60474,0.047619047619047616,0.0,0.0,P51654,Cancer
ELEMENE,0.047619047619047616,0.0,0.0,P51654,Cancer
BEPH,0.047619047619047616,0.0,0.0,P51654,Cancer
PV-701,0.047619047619047616,0.0,0.0,P51654,Cancer
PP-200,0.047619047619047616,0.0,0.0,P51654,Cancer
Didox,0.047619047619047616,0.0,0.0,P51654,Cancer
MG-4101,0.047619047619047616,0.0,0.0,P51654,Cancer
PankoMab-GEX,0.047619047619047616,0.0,0.0,P51654,Cancer
ON-09300,0.047619047619047616,0.0,0.0,P51654,Cancer
CreaVax-HCC,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
RO-4987655,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-739562,0.047619047619047616,0.0,0.0,P51654,Cancer
AZD-7507,0.047619047619047616,0.0,0.0,P51654,Cancer
P53-MDM2 binding inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
PNT-500,0.047619047619047616,0.0,0.0,P51654,Cancer
[111In]B3,0.047619047619047616,0.0,0.0,P51654,Cancer
CMX-001,0.047619047619047616,0.0,0.0,P51654,Cancer
PN-203,0.047619047619047616,0.0,0.0,P51654,Cancer
DX-2802,0.047619047619047616,0.0,0.0,P51654,Cancer
CG-701338,0.047619047619047616,0.0,0.0,P51654,Cancer
XGP-215,0.047619047619047616,0.0,0.0,P51654,Cancer
CGP-53716,0.047619047619047616,0.0,0.0,P51654,Cancer
CDX-1127,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-4989216,0.047619047619047616,0.0,0.0,P51654,Cancer
XGP-210,0.047619047619047616,0.0,0.0,P51654,Cancer
VBY- 825,0.047619047619047616,0.0,0.0,P51654,Cancer
TA-103,0.047619047619047616,0.0,0.0,P51654,Cancer
PACIS,0.047619047619047616,0.0,0.0,P51654,Cancer
EC-0565,0.047619047619047616,0.0,0.0,P51654,Cancer
Site-specific gene targeting agents,0.047619047619047616,0.0,0.0,P51654,Cancer
VAL-101,0.047619047619047616,0.0,0.0,P51654,Cancer
CV-9103,0.047619047619047616,0.0,0.0,P51654,Cancer
BBT-012,0.047619047619047616,0.0,0.0,P51654,Cancer
T-115,0.047619047619047616,0.0,0.0,P51654,Cancer
DE-310,0.047619047619047616,0.0,0.0,P51654,Cancer
NC-4016,0.047619047619047616,0.0,0.0,P51654,Cancer
RC-8800,0.047619047619047616,0.0,0.0,P51654,Cancer
Temoporfin,0.047619047619047616,0.0,0.0,P51654,Cancer
GFP-bacterial methioninase/selenomethionine GDEPT,0.047619047619047616,0.0,0.0,P51654,Cancer
SCR-44001,0.047619047619047616,0.0,0.0,P51654,Cancer
AGS-16 MAb;,0.047619047619047616,0.0,0.0,P51654,Cancer
Artemisinin derivatives,0.047619047619047616,0.0,0.0,P51654,Cancer
LHD-4,0.047619047619047616,0.0,0.0,P51654,Cancer
BMS-188797,0.047619047619047616,0.0,0.0,P51654,Cancer
90Y-cG250,0.047619047619047616,0.0,0.0,P51654,Cancer
ATI-0810,0.047619047619047616,0.0,0.0,P51654,Cancer
Fusion toxin protein,0.047619047619047616,0.0,0.0,P51654,Cancer
STA-9584,0.047619047619047616,0.0,0.0,P51654,Cancer
BBT-046,0.047619047619047616,0.0,0.0,P51654,Cancer
NSC-631570,0.047619047619047616,0.0,0.0,P51654,Cancer
WX-554,0.047619047619047616,0.0,0.0,P51654,Cancer
CPA-7,0.047619047619047616,0.0,0.0,P51654,Cancer
Org-6632,0.047619047619047616,0.0,0.0,P51654,Cancer
AVE5026,0.0,0.0,0.0,P51654,Venous thromboembolism in cancer
MDX-1140,0.047619047619047616,0.0,0.0,P51654,Cancer
MAb 224G11,0.047619047619047616,0.0,0.0,P51654,Cancer
SL-201,0.047619047619047616,0.0,0.0,P51654,Cancer
SOM-0002,0.047619047619047616,0.0,0.0,P51654,Cancer
MG-401,0.047619047619047616,0.0,0.0,P51654,Cancer
CL-329753,0.047619047619047616,0.0,0.0,P51654,Cancer
Compound 45,0.047619047619047616,0.0,0.0,P51654,Cancer
CGP-52411,0.047619047619047616,0.0,0.0,P51654,Cancer
MDAM (y-methylene-10-deazaaminopterin),0.047619047619047616,0.0,0.0,P51654,Cancer
HG-1097,0.047619047619047616,0.0,0.0,P51654,Cancer
ACTB-1003,0.047619047619047616,0.0,0.0,P51654,Cancer
Fluoroglycoconjugates,0.047619047619047616,0.0,0.0,P51654,Cancer
KI-1001,0.047619047619047616,0.0,0.0,P51654,Cancer
IGFR1 kinase inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
Salvicine,0.047619047619047616,0.0,0.0,P51654,Cancer
MOR-206,0.047619047619047616,0.0,0.0,P51654,Cancer
MOR-205,0.047619047619047616,0.0,0.0,P51654,Cancer
MOR-203,0.047619047619047616,0.0,0.0,P51654,Cancer
AR-54,0.047619047619047616,0.0,0.0,P51654,Cancer
C-met mAbs,0.047619047619047616,0.0,0.0,P51654,Cancer
IGN-312,0.047619047619047616,0.0,0.0,P51654,Cancer
IGN-311,0.047619047619047616,0.0,0.0,P51654,Cancer
NMS-P715,0.047619047619047616,0.0,0.0,P51654,Cancer
DW-2282,0.047619047619047616,0.0,0.0,P51654,Cancer
CEL-1000,0.047619047619047616,0.0,0.0,P51654,Cancer
PHY-808,0.047619047619047616,0.0,0.0,P51654,Cancer
XL019,0.047619047619047616,0.0,0.0,P51654,Cancer
Rinfabate,0.047619047619047616,0.0,0.0,P51654,Cancer
PL-225B,0.047619047619047616,0.0,0.0,P51654,Cancer
CWP-231,0.047619047619047616,0.0,0.0,P51654,Cancer
SP-1031C,0.047619047619047616,0.0,0.0,P51654,Cancer
PIM protein kinase inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
AKT inhibitors [PMCID,0.047619047619047616,0.0,0.0,P51654,Cancer
CK-37,0.047619047619047616,0.0,0.0,P51654,Cancer
CBLC-4H10,0.047619047619047616,0.0,0.0,P51654,Cancer
NCL-00016149,0.047619047619047616,0.0,0.0,P51654,Cancer
OPB-31121,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
PBI-05204,0.047619047619047616,0.0,0.0,P51654,Cancer
GTP-200,0.047619047619047616,0.0,0.0,P51654,Cancer
KI-0904,0.047619047619047616,0.0,0.0,P51654,Cancer
KI-0901,0.047619047619047616,0.0,0.0,P51654,Cancer
Radiolabeled onartuzumab,0.047619047619047616,0.0,0.0,P51654,Cancer
CME-548,0.047619047619047616,0.0,0.0,P51654,Cancer
OG-232,0.047619047619047616,0.0,0.0,P51654,Cancer
INGN-402,0.047619047619047616,0.0,0.0,P51654,Cancer
EVIRNA,0.047619047619047616,0.0,0.0,P51654,Cancer
RHAMM-R3 peptide vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
ISIS 18078,0.047619047619047616,0.0,0.0,P51654,Cancer
PCI-34051,0.047619047619047616,0.0,0.0,P51654,Cancer
Oltipraz,0.047619047619047616,0.0,0.0,P51654,Cancer
ON-128,0.047619047619047616,0.0,0.0,P51654,Cancer
Nordihydroguaiaretic acid,0.047619047619047616,0.0,0.0,P51654,Cancer
ON-123,0.047619047619047616,0.0,0.0,P51654,Cancer
AVR-168,0.047619047619047616,0.0,0.0,P51654,Cancer
Simotaxel,0.047619047619047616,0.0,0.0,P51654,Cancer
TL-1892,0.047619047619047616,0.0,0.0,P51654,Cancer
Glyfoline,0.047619047619047616,0.0,0.0,P51654,Cancer
Recombinant opticin,0.047619047619047616,0.0,0.0,P51654,Cancer
GGTI-2418,0.047619047619047616,0.0,0.0,P51654,Cancer
NKP-3752,0.047619047619047616,0.0,0.0,P51654,Cancer
Sch-207758,0.047619047619047616,0.0,0.0,P51654,Cancer
IRC-083927,0.047619047619047616,0.0,0.0,P51654,Cancer
CH-4938056,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-5177624,0.047619047619047616,0.0,0.0,P51654,Cancer
IGFBP 2 variants,0.047619047619047616,0.0,0.0,P51654,Cancer
OM-294-DP,0.047619047619047616,0.0,0.0,P51654,Cancer
AR-12,0.047619047619047616,0.0,0.0,P51654,Cancer
K252a,0.047619047619047616,0.0,0.0,P51654,Cancer
BKT-120,0.047619047619047616,0.0,0.0,P51654,Cancer
HuMax-TF,0.047619047619047616,0.0,0.0,P51654,Cancer
Carmofur,0.047619047619047616,0.0,0.0,P51654,Cancer
OGX-427,0.047619047619047616,0.0,0.0,P51654,Cancer
SAR245409,0.0,0.0,0.0,P51654,Pediatric cancer
RO-5126766,0.047619047619047616,0.0,0.0,P51654,Cancer
BI-638683,0.047619047619047616,0.0,0.0,P51654,Cancer
SMC-0006 prodrug,0.047619047619047616,0.0,0.0,P51654,Cancer
BL-Angiostatin,0.047619047619047616,0.0,0.0,P51654,Cancer
CAB-103,0.047619047619047616,0.0,0.0,P51654,Cancer
AR-mTOR-26,0.047619047619047616,0.0,0.0,P51654,Cancer
ABJ-879,0.047619047619047616,0.0,0.0,P51654,Cancer
AVR-147,0.047619047619047616,0.0,0.0,P51654,Cancer
Fsn-0503,0.047619047619047616,0.0,0.0,P51654,Cancer
C4.4a-ADC,0.047619047619047616,0.0,0.0,P51654,Cancer
ATL-104,0.047619047619047616,0.0,0.0,P51654,Cancer
APCK-110,0.047619047619047616,0.0,0.0,P51654,Cancer
SERMs,0.047619047619047616,0.0,0.0,P51654,Cancer
Caracemide,0.047619047619047616,0.0,0.0,P51654,Cancer
MLN8237,0.047619047619047616,0.0,0.0,P51654,Cancer
GB-2542,0.047619047619047616,0.0,0.0,P51654,Cancer
Avelumab,0.047619047619047616,0.0,0.0,P51654,Cancer
BB-15600,0.047619047619047616,0.0,0.0,P51654,Cancer
AX-13057,0.047619047619047616,0.0,0.0,P51654,Cancer
PX-866,0.047619047619047616,0.0,0.0,P51654,Cancer
VER-82160,0.047619047619047616,0.0,0.0,P51654,Cancer
18F-fluoromethylallylcholine,0.047619047619047616,0.0,0.0,P51654,Cancer
Aclarubicin,0.047619047619047616,0.0,0.0,P51654,Cancer
Glionitrin A,0.047619047619047616,0.0,0.0,P51654,Cancer
PMA-406,0.047619047619047616,0.0,0.0,P51654,Cancer
OPB-111077,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
BS-194,0.047619047619047616,0.0,0.0,P51654,Cancer
B-428,0.047619047619047616,0.0,0.0,P51654,Cancer
NVX-188,0.047619047619047616,0.0,0.0,P51654,Cancer
TES-23-NCS,0.047619047619047616,0.0,0.0,P51654,Cancer
MB07133,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
NP-50501,0.047619047619047616,0.0,0.0,P51654,Cancer
BE-13793C,0.047619047619047616,0.0,0.0,P51654,Cancer
Dual PI3K/mTOR inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
ARRY-886,0.047619047619047616,0.0,0.0,P51654,Cancer
NIM-811,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-06439535,0.047619047619047616,0.0,0.0,P51654,Cancer
SB-41947,0.047619047619047616,0.0,0.0,P51654,Cancer
MNX-200,0.047619047619047616,0.0,0.0,P51654,Cancer
VE-821,0.047619047619047616,0.0,0.0,P51654,Cancer
VXM-01,0.047619047619047616,0.0,0.0,P51654,Cancer
LP-20104,0.047619047619047616,0.0,0.0,P51654,Cancer
Pretarget technology,0.047619047619047616,0.0,0.0,P51654,Cancer
Panomifene,0.047619047619047616,0.0,0.0,P51654,Cancer
PEG-LPA-2,0.047619047619047616,0.0,0.0,P51654,Cancer
VER-54505,0.047619047619047616,0.0,0.0,P51654,Cancer
ALKASAR-18,0.047619047619047616,0.0,0.0,P51654,Cancer
EBC-46,0.047619047619047616,0.0,0.0,P51654,Cancer
MORAb-28,0.047619047619047616,0.0,0.0,P51654,Cancer
BAY-61-2116,0.0,0.0,0.0,P51654,Pediatric cancer
Anti-FGFR1 mAb program,0.047619047619047616,0.0,0.0,P51654,Cancer
RBT-401,0.047619047619047616,0.0,0.0,P51654,Cancer
Ibulocydine,0.047619047619047616,0.0,0.0,P51654,Cancer
D-21775,0.047619047619047616,0.0,0.0,P51654,Cancer
CC49 humanized radioimmunoconjugates,0.047619047619047616,0.0,0.0,P51654,Cancer
MK-6592,0.047619047619047616,0.0,0.0,P51654,Cancer
MBI 1121,0.047619047619047616,0.0,0.0,P51654,Cancer
Custirsen,0.047619047619047616,0.0,0.0,P51654,Cancer
TL-1836,0.047619047619047616,0.0,0.0,P51654,Cancer
CAP-3.2,0.047619047619047616,0.0,0.0,P51654,Cancer
P70S6 kinase inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
PWT-33597,0.047619047619047616,0.0,0.0,P51654,Cancer
HM-5016699,0.047619047619047616,0.0,0.0,P51654,Cancer
APN-401,0.047619047619047616,0.0,0.0,P51654,Cancer
Epstein Barr-based gene therapy,0.047619047619047616,0.0,0.0,P51654,Cancer
KI-0502,0.047619047619047616,0.0,0.0,P51654,Cancer
DasKloster 0014-01,0.047619047619047616,0.0,0.0,P51654,Cancer
Encapsulated cancer cells,0.047619047619047616,0.0,0.0,P51654,Cancer
CX-9051,0.047619047619047616,0.0,0.0,P51654,Cancer
CDK2 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
Anti-TAG-72 antibody,0.047619047619047616,0.0,0.0,P51654,Cancer
MIP-1231,0.047619047619047616,0.0,0.0,P51654,Cancer
INGN-007,0.047619047619047616,0.0,0.0,P51654,Cancer
Interferon gamma-1a,0.047619047619047616,0.0,0.0,P51654,Cancer
LY2940680,0.047619047619047616,0.0,0.0,P51654,Cancer
Centanamycin,0.047619047619047616,0.0,0.0,P51654,Cancer
TAR-1,0.047619047619047616,0.0,0.0,P51654,Cancer
NVX-144,0.047619047619047616,0.0,0.0,P51654,Cancer
OBP-801,0.047619047619047616,0.0,0.0,P51654,Cancer
EP-302,0.047619047619047616,0.0,0.0,P51654,Cancer
ABT-518,0.047619047619047616,0.0,0.0,P51654,Cancer
B-06,0.047619047619047616,0.0,0.0,P51654,Cancer
CNDO-109,0.047619047619047616,0.0,0.0,P51654,Cancer
T-607,0.047619047619047616,0.0,0.0,P51654,Cancer
CNDO-113,0.047619047619047616,0.0,0.0,P51654,Cancer
SN-28049,0.047619047619047616,0.0,0.0,P51654,Cancer
MTL-104,0.047619047619047616,0.0,0.0,P51654,Cancer
ME-344,0.047619047619047616,0.0,0.0,P51654,Cancer
ABX-103,0.047619047619047616,0.0,0.0,P51654,Cancer
NMB-T-BMX-OS01,0.047619047619047616,0.0,0.0,P51654,Cancer
ABX-101,0.047619047619047616,0.0,0.0,P51654,Cancer
ABX-102,0.047619047619047616,0.0,0.0,P51654,Cancer
AG-024322,0.047619047619047616,0.0,0.0,P51654,Cancer
IMGN-009,0.047619047619047616,0.0,0.0,P51654,Cancer
IMGN-007,0.047619047619047616,0.0,0.0,P51654,Cancer
GTx-230,0.047619047619047616,0.0,0.0,P51654,Cancer
RG-83852,0.047619047619047616,0.0,0.0,P51654,Cancer
TG02,0.047619047619047616,0.0,0.0,P51654,Cancer
Sarkomycin,0.0,0.0,0.0,P51654,Diabetic nephropathies
RNAi therapeutics; GeneSegues Inc,0.047619047619047616,0.0,0.0,P51654,Cancer
Engineered toxin bodies,0.047619047619047616,0.0,0.0,P51654,Cancer
PF-3475952,0.047619047619047616,0.0,0.0,P51654,Cancer
AMP-423,0.047619047619047616,0.0,0.0,P51654,Cancer
PND-1186,0.047619047619047616,0.0,0.0,P51654,Cancer
TGF-beta Shield,0.047619047619047616,0.0,0.0,P51654,Cancer
AV-203,0.047619047619047616,0.0,0.0,P51654,Cancer
UNBS-1450,0.047619047619047616,0.0,0.0,P51654,Cancer
Tumor-associated macrophage immunotherapy,0.047619047619047616,0.0,0.0,P51654,Cancer
PB-102,0.047619047619047616,0.0,0.0,P51654,Cancer
EHT-107,0.047619047619047616,0.0,0.0,P51654,Cancer
Palbociclib,0.047619047619047616,0.0,0.0,P51654,Cancer
HuMax-VEGF,0.047619047619047616,0.0,0.0,P51654,Cancer
Hylenex,0.047619047619047616,0.0,0.0,P51654,Cancer
Dhaq diacetate,0.047619047619047616,0.0,0.0,P51654,Cancer
LA22-radioimmunoconjugates,0.047619047619047616,0.0,0.0,P51654,Cancer
DHF-18,0.047619047619047616,0.0,0.0,P51654,Cancer
HuMax-Her2,0.047619047619047616,0.0,0.0,P51654,Cancer
KB-9520,0.047619047619047616,0.0,0.0,P51654,Cancer
GSK-2334470,0.047619047619047616,0.0,0.0,P51654,Cancer
Fluorapacin,0.047619047619047616,0.0,0.0,P51654,Cancer
IPH-3102,0.047619047619047616,0.0,0.0,P51654,Cancer
HI-con1,0.047619047619047616,0.0,0.0,P51654,Cancer
HX-01,0.047619047619047616,0.0,0.0,P51654,Cancer
KA-40X,0.047619047619047616,0.0,0.0,P51654,Cancer
RR-1,0.047619047619047616,0.0,0.0,P51654,Cancer
58-1066,0.047619047619047616,0.0,0.0,P51654,Cancer
VB2-011,0.047619047619047616,0.0,0.0,P51654,Cancer
Triplex-forming oligonucleotides,0.047619047619047616,0.0,0.0,P51654,Cancer
Tegafur,0.047619047619047616,0.0,0.0,P51654,Cancer
MAbs targeting PAR-1,0.047619047619047616,0.0,0.0,P51654,Cancer
PAN-90806,0.047619047619047616,0.0,0.0,P51654,Cancer
AstaFactor,0.047619047619047616,0.0,0.0,P51654,Cancer
INOC-005,0.047619047619047616,0.0,0.0,P51654,Cancer
HD-201,0.047619047619047616,0.0,0.0,P51654,Cancer
B7-2/GM-CSF cancer gene therapy vaccine,0.047619047619047616,0.0,0.0,P51654,Cancer
IMM-160,0.0,0.0,0.0,P51654,Hepatocellular carcinoma
Ether lipid,0.047619047619047616,0.0,0.0,P51654,Cancer
Phospho-aspirins,0.047619047619047616,0.0,0.0,P51654,Cancer
Lysine-specific demethylase 1 inhibitors,0.047619047619047616,0.0,0.0,P51654,Cancer
YM-116,0.047619047619047616,0.0,0.0,P51654,Cancer
MIP-1267,0.047619047619047616,0.0,0.0,P51654,Cancer
INOC-002,0.047619047619047616,0.0,0.0,P51654,Cancer
INOC-003,0.047619047619047616,0.0,0.0,P51654,Cancer
MP-AA-1,0.047619047619047616,0.0,0.0,P51654,Cancer
Oncoprev,0.047619047619047616,0.0,0.0,P51654,Cancer
EP-342,0.047619047619047616,0.0,0.0,P51654,Cancer
Celmoleukin,0.047619047619047616,0.0,0.0,P51654,Cancer
TTAC-0001,0.047619047619047616,0.0,0.0,P51654,Cancer
ON-24160,0.047619047619047616,0.0,0.0,P51654,Cancer
